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ABSTRACT 
 
Multimodal Optical Imaging for Detection of Cervical Neoplasia 
 
by 
 
Tefo Caddrouse Bubi  
 
Despite being the most preventable cancer, cervical cancer remains the third leading 
cause of cancer death worldwide. Over 85% of cervical cancer incidence and mortality occurs in 
low-resource countries where screening programs for early detection are either inadequate or 
unavailable. In the developed world, where screening programs are well organized, incidence 
and mortality rates are greatly reduced.  Recent advances in optical imaging have the potential to 
enable cervical cancer screening at the point-of-care, even in the hands of less experienced 
providers.  High performance optical imaging systems can be constructed at relatively low cost, 
and image analysis can be automated; thus, these technologies may provide a way to bridge the 
gap to cervical cancer screening for developing countries. This work focuses on the design, 
construction, and clinical testing of a novel multimodal optical imaging (combination of wide-
field imaging and high-resolution) for early detection of cervical neoplasia.   
The Multimodal Digital Imager (MDI) acquires in vivo images of cervical tissue in 
fluorescence, narrow band reflectance, and orthogonal polarized reflectance modes using multiple 
illumination wavelengths.  The High Resolution Microendoscope (HRME) was used to interrogate 
  
clinically suspicious areas with subcellular spatial resolution, revealing changes in nuclear to 
cytoplasmic area ratio. 
In vivo image data from the wide-field system was combined with image data from a 
high- resolution microendoscope (HRME) in order to test the effectiveness of the multimodal 
optical imaging in discriminating between cervical neoplasia and non-neoplastic.  Multimodal 
optical imaging coupled with computer aided diagnostic achieved a sensitivity of 82% and 
specificity of 85% for discriminating cervical neoplastic from non-neoplastic  
This work has demonstrated that multimodal optical imaging; combination of wide-field 
and high-resolution optical imaging of the cervix can assist in the detection of cervical neoplasia 
and can be implemented effectively in a low-resource setting. 
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1. INTRODUCTION 
1.1 Overview  
The main objective of this research is to evaluate whether multimodal optical imaging (a 
combination of wideǦfield and highǦresolution optical imaging) of the cervix can assist clinicians 
in detecting dysplastic (precancerous) areas, in a bid to provide screening alternatives to the low-
resourced world.  
It is important to detect and treat precancerous lesions of the cervix before they develop into 
cancer. Cervical precancers are typically associated with architectural, morphologic and 
molecular changes that are normally detected via cytology and/or histology.  
Recent advances in fiber optics, optical detectors, and computer-aided image analysis have given 
rise to new optical imaging systems with the potential to image cells or tissue, revealing 
architectural and morphologic disease characteristics without the need for tissue removal. Optical 
imaging systems are able to obtain and display both wide-field and highǦresolution images of 
epithelial tissues in realǦtime. Wide-field systems enable relatively large fields of view (50-100 
mm) to be visualized at moderate resolution under conventional whiteǦlight illumination, as well 
as in fluorescence and polarized light modes. Advances in wide-field narrow-band reflectance 
imaging can also be utilized to enhance vascular contrast. High-resolution optical imaging 
techniques have been used to observe morphologic and architectural changes in cells that 
indicate neoplastic transformation. Such indicators are changes in the size and internal structure 
of the nucleus, the disorganization of cells, pleomorphism, and other cellular changes that require 
imaging with spatial resolution on the order of a few microns. Fluorescent contrast agents are 
also available to enhance visualization of suspicious lesions by increasing the signal to 
background ratio.  
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A combination of these advances was explored to aid in the detection of cervical intraepithelial 
neoplasia (CIN). Wide-field imaging was used to rapidly image the entire cervix and identify 
regions which are suspicious for neoplasia with high sensitivity, while high-resolution imaging 
used to interrogate suspicious regions identified in wide-field imaging with high spatial 
resolution, confirming the presence or absence of neoplasia with high specificity. In vivo studies 
were performed to determine the imaging techniques and parameters which maximize diagnostic 
performance. Finally, data acquired in vivo were used to develop and evaluate image analysis 
algorithms acquired using these optimal parameters. 
 
1.2 Objective and Specific Aims 
Specific Aim 1: A multimodal wide-field optical imaging system termed the Multimodal 
Digital Imager (MDI) was designed, constructed and its performance characterized. The MDI is 
capable of narrowband green reflectance, cross-polarized reflectance, and fluorescence imaging 
across the entire field of view of the cervix, with moderate spatial resolution. 
 
Specific Aim 2: An in vivo pilot study involving 26 patients in Gaborone, Botswana was 
conducted using the MDI and a high-resolution micro-endoscope (HRME) previously developed 
in our lab.  The imaging parameters of the systems were optimized, and the ability of each 
individual system to discriminate cervical cancer from normal tissue relative to the gold standard 
of histopathology established. Data from these 26 patients were used to optimize image analysis 
parameters, and served as a training set to develop and evaluate automated, quantitative image 
processing algorithms.  
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Specific Aim 3: A larger study involving 60 patients in a high prevalence population in 
Botswana was conducted. Images were obtained with the wide-field system and the high-
resolution microendoscope. Data were analyzed using algorithms optimized in the training set to 
determine the sensitivity and specificity of the wide-field and high-resolution optical imaging. 
 
1.3 Summary  
This dissertation describes the development of novel, multimodal optical imaging devices 
for diagnosis of cervical cancer that can be implemented as diagnostic aids in high-prevalence 
patient populations. Optical modalities and conditions that could provide improved information 
on the presence of cervical lesions in vivo were explored using these devices. Previous studies 
investigated the ability of some individual optical imaging devices to identify lesions, however, 
this is the first work to combine multiple modalities including multimodal wide-field and high-
resolution imaging of the cervix, with the intention to improve detection accuracy. 
The dissertation is organized as follows: Chapter 2 presents relevant background 
information on cervical cancer and premalignant lesions. Current methods for detection and 
diagnosis are discussed. The role of optics in cancer is also discussed together with current 
optical diagnostic techniques. Chapter 3 reports initial results of in vivo pilot study on the cervix 
using the high-resolution microendoscopy system. Quantitative image analysis algorithms were 
developed that demonstrate the ability of the microendoscope to distinguish between neoplastic 
and non-neoplastic tissue in human cervical squamous epithelium. To demonstrate the ability of 
the microendoscope system to give consistent results in detecting neoplastic lesions in the cervix, 
Chapter 4 presents results from a larger study. These results are used as a validation set to test 
the algorithms developed in chapter 3. Chapter 5 presents the design and performance 
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characteristics of the multimodal digital imager (MDI). Initial results of a study on the MDI 
system including in vivo imaging of the cervix are presented. Chapter 6 seeks to investigate the 
ability of integrating the microendoscope system with other wide-field systems. Data from the 
microendoscope system were combined with data from the wide-field system in order to 
maximize sensitivity and specificity. Chapter 7 summarizes and discusses the important findings 
and implications of this dissertation. 
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2.  BACKGROUND 
2.1 Motivation and Significance  
Cervical cancer is the third most common type of cancer in women worldwide. In 2008, 530,000 
new cases and 275,000 deaths from cervical cancer were estimated [1]. Over 85% of cervical 
cancer incidence and mortality occur in developing countries where screening programs for early 
detection are either 
inadequate or unavailable [1]. 
It is estimated that this 
number will be 90% by 2020 
if no major interventions are 
carried out now [2, 3]. 
Cervical cancer incidence 
and mortality rates are 
highest in sub-Saharan Africa 
where incidence rates are 
nearly 7 times higher than 
that of North America, and 
mortality rates are 15 times 
as high [2].  
In developed countries, organized screening tests such as the Papanicolaou smear have enabled 
precancerous lesions to be diagnosed and treated early, subsequently reducing new cervical 
cancer cases and mortality rates. However, to be effective, these screening programs require 
relatively high-level infrastructure and well-trained personnel.  
Figure1.  Cervical cancer cases reported every year from 1986 to 
2007. The graph shows a sharp growth of number of cases from 1997 
and the values have been rising since then. The data were collected 
by the Ministry of Health, Botswana (2008) [4]. 
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Cervical cancer affects mostly young women in developing countries who are in their most 
productive years. Most of these patients have this insidious disease due to late detection, when 
treatment is particularly difficult. Late detection is due to a lack of or inadequate screening 
tools/programs because of financial and personnel constraints. 
In Botswana, where we carried out research, cervical cancer accounted for over 24% of all 
cancers among 
women in 2007 [4]. 
Botswana has high 
HIV/AIDS incidence 
rates and with studies 
showing HIV 
correlation to HPV 
and cervical neoplasia 
[5], it is not surprising 
to see an increase of 
cervical cancer during 
the HIV era. Figure 1 
shows the growth in 
the number of 
reported cases of 
cervical cancer in Botswana over the past 21 years [4]. Due to rising incidence, improving early 
diagnosis at the point-of-care is particularly important in this setting.  
 
Figure 2. Five-year survival rates of cervical cancer patients diagnosed by stage 
showing the impact of early detection on prognosis [8] 
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Cervical cancer is almost 100% curable when detected early [6]. The 5-year survival rates for 
cervical cancer are strongly dependent on the stage of diagnosis. Figure 2 shows the correlation 
between survival rates and stage at diagnosis. 
Current screening and diagnosis of cervical precancer involves collection of cells from the cervix 
by a cytology test (Pap smear). The 70% decrease in the incidence of cervical cancer in the US 
has been credited in a large part to the widespread use of the Papanicolaou smear [7]. An 
abnormal Pap smear is followed by colposcopy, an optically based technique developed in the 
HDUO\¶V>6]. A colposcope is a low-power microscope that illuminates and magnifies the 
FHUYL[WRKHOSWDNHGLUHFWHGELRSVLHVRIWKHDEQRUPDODSSHDULQJWLVVXH$FHWLFDFLGDQG/XJRO¶V
iodine have been used with the colposcope to improve optical contrast. Because of the low 
specificity (48%) of colposcopy, a biopsy is required to confirm disease [8]. This low specificity 
leads to over-diagnosis of low-grade lesions, hence the need for biopsy confirmation.  
Of late, there have been significant improvements in colposcopy to enhance contrast. Green 
filters have been incorporated to further enhance vascular contrast, highlighting suspicious 
regions. Digital colposcopes have also been developed to collect digital images which can be 
analyzed visually or using image analysis algorithms.  
In developed countries the incidence and mortality rates of cervical cancer have been greatly 
decreased due to this approach. Further reduction is anticipated with the latest HPV vaccine 
developments, since about 70% of cervical cancer is caused by the high-risk HPV infections 
covered by available vaccines. 
 The necessity of biopsy to confirm colposcopic impression leads to the need for extensive 
infrastructure, personnel and economic resources. This expensive approach is not possible to 
implement in developing countries, and, as a result, a majority of women die from the disease 
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due to diagnosis at late stage. Early cervical cancer detection methods that are accurate but less 
expensive and that allow immediate treatment and prevention methods are crucial for low-
resourced countries. 
 
 
2.2 Cervix  
2.2.1 Normal Anatomy and histology  
7KHFHUYL[LVWKHORZHUSDUWRIWKHXWHUXVRQWKHYDJLQDOVLGH,WLVDOVRUHIHUUHGWRDV³QHFNRIWKH
XWHUXV´7KHFHUYL[LVDERXW-5cm in diameter but varies depenGLQJRQWKHZRPDQ¶VDJHDQG
hormonal status. Figure 3 shows a diagram of the lower female genital tract and shows the  
location of the cervix [9]. The cervix has four main parts: Ectocervix; the portion projecting into 
the vagina, External os; opening of the ectocervix, Endocervix; the canal of the cervix 
connecting the external os 
to the internal os, Internal 
os; the opening of the 
cervix into the uterine 
cavity [10, 11].  
The cervix is lined by two 
types of epithelium. The 
ectocervix is composed of 
non-keratinized stratified 
squamous epithelium while 
the endocervix is composed of simple columnar epithelium [9 - 12]. The fact that there are two 
types of epithelium present is important because their optical properties are different.  
Figure 3.  Structure of the female genital tract [13]. 
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The squamous tissue of the ectocervix consists of three distinct epithelial layers; the superficial 
top layer that consists of mature cells, the intermediate layer that consists of maturing cells, and 
the basal layer that consists of metabolically active, mitotic cells that regenerate the epithelium. 
Mature squamous epithelium contains abundant glycogen, hence changes color after application 
RI/XJRO¶VLRGLQH7KHIHPDOH hormone, estrogen is responsible for the maturation of the 
squamous epithelium.  
The columnar/glandular tissue of the endocervix consists mainly of columnar cells with 
glandular structures for mucous secretion. It is composed of a single layer of tall cells. It is in the 
columnar epithelium where endocervical crypts form. The columnar epithelium does not contain 
glycogen. Due to the absence of glycogen, columnar epithelium does not change color after 
DSSOLFDWLRQRI/XJRO¶VLRGLQH7KLVLVRQHZD\WRGLVWLQguish squamous and columnar epithelium.  
 
The area at the border of the squamous and columnar tissue is called the transformation zone. 
There are normal physiological changes that cause metaplasia in the transformation zone 
including menopause, puberty, and the menstrual cycle. Metaplasia is the replacement of the 
columnar epithelium by squamous epithelium. The environment of the ectocervix is different 
from that of the endocervix, the former being slightly acidic. When the endocervix is exposed to 
the acidic conditions of the vagina it will undergo metaplasia. Metaplasia is a normal, non-
cancerous process that every woman undergoes in her life [13 - 15].  
Some human papillomavirus (HPV) types insult the squamous metaplastic region 
resulting in nuclear and cytoplasmic abnormalities [10]. If the infection is not cleared by the 
SDWLHQW¶VLPPXQHV\VWHPWKLVEHQLJQFRQGLWLRQLVFDSDEOHRIEHFRPLQJG\VSODVWLFDQGWKHQ
cancerous.  
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Close attention should be given to the transformation zone because metaplasia occurs here and it 
has a higher risk of becoming dysplastic and then cancerous.  
 
2.2.2 The Dysplasia to Carcinoma Sequence  
Invasive cervical cancers can be prevented since they are preceded by a long phase of 
preinvasive disease (dysplasia). Cervical dysplasia refers to abnormal cell growth of the cervix. 
Cervical dysplasia is caused by infection of the cervix with the human papillomavirus (HPV) 
infection, which is transmitted through sexual contact. HPV 16 and 18 have been associated with 
about 70% of severe dysplasia and cervical cancer. HPV 6 and 11 are strongly associated with 
genital warts. The 
immune system 
attempts to clear these 
infections, and about 
90% are cleared within 
two years.  
Cervical dysplasia is 
divided into low-grade 
squamous 
intraepithelial lesions 
(LGSIL) and high-
grade squamous intraepithelial lesions (HGSIL). LGSIL includes koilocytic atypia and CIN 1, 
while HGSIL includes CIN 2 & 3. CIN refers to cervical intraepithelial neoplasia. In CIN 1, the 
lower 1/3 of the epithelium includes precancerous cells. In CIN 2, the lower 1/2 of the epithelium 
     
   
 
Figure 4 showing a progression from normal to invasive cervical cancer [16]. 
(A) Normally squamous epithelium, (B) CIN1 (koilocytosis and cytonuclear atypia), 
(C) CIN 2 (1/2 of epithelium dysplastic), (D) CIN 3: 2/3 of epithelium dysplastic. 
 
C D 
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includes precancerous cells, and in CIN 3, the lower 2/3 of the epithelium includes precancerous 
cells. Figure 4 [16] shows the progression from normal epithelium to HGSIL. In CIN 1 there are 
just a few abnormal cells growing in the basal layer, while in CIN 2, about half of the cells are 
abnormal beginning in the basal layer, and in CIN 3 more than two-thirds of the cells are 
abnormal. When the entire epithelium is filled with precancerous cells which have not yet spread 
below the surface, the lesion is referred to as carcinoma-in-situ (CIS) [17]. When carcinoma in 
situ is left untreated, it can often progress to invasive cervical cancer, where the neoplastic cells 
invade the tissue underlying the basement membrane. There are two main types of invasive 
cervical cancer: squamous cell cancer arising from the squamous epithelium that covers the 
ectocevix, and adenocarcinoma arising from the glandular cells of the endocervical canal. About 
90% of cervical cancers are squamous cell cancers. Adenocarcinomas account for 10% of 
cervical cancer but are becoming more common in women born in the last two and three decades 
[18]. 
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2.3 Current and emerging methods of Early Detection and Prevention 
There is clear disparity between the incidence and mortality of cervical cancer in developed and 
developing countries. These disparities arise primarily as a result of the resources available for 
screening and early detection programs in these areas. Developed countries have organized 
screening programs to detect and treat cervical cancer and its precancers. However, for proper 
implementation, these programs require extensive infrastructure, personnel and economic 
resources. Unfortunately, these resources are not readily available in developing countries. 
Researchers have embarked on finding screening alternatives adoptable in developing nations.    
 
2.3.1 Resource Intensive Regions 
2.3.1.1 Pap smear and Colposcopy 
In developed countries the current paradigm for screening and diagnosis of cervical precancer 
involves collection of cells from the cervix by a cytology test (Pap smear). Any abnormal Pap 
smear is followed by an optically based technique, called colposcopy [6], first described by 
+LQVHOPDQQLQWKHHDUO\¶V$FROSRVFRSHLVDORZ-power microscope that illuminates and 
magnifies the cervix, helping the colposcopist to visually discriminate normal from abnormal 
tissue and to take directed biopsies of abnormal tissue. AFHWLFDFLGDQG/XJRO¶VLRGLQHKDYHEHHQ
used with the colposcope to improve optical contrast. Upon application of 3-5% acetic acid, 
VXVSLFLRXVDUHDVWXUQZKLWHWKHSKHQRPHQRQLVUHIHUUHGWRDV³DFHWRZKLWHQLQJ´7KLVLVEHOLHYHG
to come about because of increased cellular protein and increased nuclear density [8, 19, and 20]. 
/XJRO¶VLRGLQHLVJO\FRSKLOLF that is the epithelium containing glycogen takes up the iodine. 
Normal squamous epithelium contains glycogen hence is expected to take up iodine, staining 
dark brown or black, while columnar epithelium contains no glycogen and hence remains 
13 
 
XQVWDLQHG&,1DQGFDQFHUFRQWDLQOHVVRUQRJO\FRJHQDQGGRQ¶WVWDLQXSRQDSSOLFDWLRQRI
iodine. Any areas in the squamous epithelium that remain unstained after application of iodine 
are therefore suspected to be dyplastic or cancerous.   The colposcope is used to identify which 
regions of tissue should be biopsied. Biopsied tissue is then sent to a pathologist for further 
histologic analysis. Following confirmation of presence disease by histopathology, precancerous 
lesions are effectively treated using outpatient ablative or excisional techniques such as 
cryotherapy or loop electrosurgical excision procedure (LEEP), preventing the development of 
cervical cancer. 
This process of evaluation is not only expensive but also time consuming. In developing 
countries, it can often require between 3 weeks to 6 months to obtain biopsy results, due to 
shortages in the number of trained pathologists.  This can result in poor patient follow up, as 
patients must often travel long distances to receive medical attention. Also the three steps of this 
SURFHVVDUHODUJHO\VXEMHFWLYHLQYROYLQJWKUHHGLIIHUHQWFOLQLFLDQ¶VDVVHVVPHQWRIWKUHHGLVWLQFW
pathological entities. 
The Pap smear test has an average sensitivity and specificity of 73% and 63% [21]. The low 
sensitivity leads to missed high-grade lesions and low specificity to over-diagnosed low-grade 
lesions. There is therefore the need for colposcopy. However, even in the hands of an expert, a 
low specificity of about 48% has been reported when differentiating abnormal from normal 
tissues [8]. A biopsy is therefore required to confirm disease, exposing patients to unnecessary 
biopsies. Biopsies significantly increase the cost; over US$6B are spent annually in the United 
States to evaluate and treat atypias [22].  
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2.3.1.2 HPV Vaccines 
Cervical cancer is caused by high-risk types of human papillomavirus (HPV). DNA from HPV 
16 & 18 is found in more than 70% of squamous cell carcinomas [23, 24, and 25]. HPV is 
transmitted through sexual intercourse and approximately 70% of cervical cancers are caused by 
HPV 16 & 18 [24- 28]. Two vaccines, Gardasil and Cervarix, have recently been developed to 
protect against HPV 16 & 18.  Gardasil has been studied in over 27,000 women in 33 countries 
and has received FDA licensing and is available in more than 60 countries [29]. The efficacy 
results for prevention of HPV 16 & 18 infection have been consistent in all these countries. 
Vaccines to prevent HPV infection that have been developed may further reduce the incidence of 
cervical cancer in countries where vaccines are available [28].  However, the high cost of 
vaccines, cultural acceptability, public support and political or logistical barriers could delay 
implementation of these vaccines in many developing countries [30]. In USA, the three-dose 
vaccine costs about $360 [31]; this is a major barrier to implement in countries with a gross 
domestic product of less than $1,000 per capita. The vaccine is effective only against HPV 16 & 
18, which account for about 70% of cervical cancers, therefore routine cervical cancer screening 
is still essential even for vaccinated women to catch the other 30% cervical cancers not covered 
by the vaccinations.   
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2.3.2 Resource limited regions 
2.3.2.1 HPV-DNA testing and Visual Inspection with acetic Acid (VIA) 
Due to costs associated with cervical cancer surveillance methods used in developed countries it 
is almost impossible to use the same approach in developing countries.  
Efforts have been made to provide cost-effective screening/diagnosis tools, such as DNA testing 
for HPV and simple visual inspection with acetic acid (VIA) in resource limited regions. HPV 
DNA testing has shown promising results when complementing cytology in primary screening 
[32, 33].  Goldie et al evaluated a variety of cervical cancer screening techniques for cost 
effectiveness in five different countries; India, Kenya, Peru, South Africa and Thailand. The 
HPV DNA test showed promising results with sensitivity and specificity of HPV DNA varying 
from 65% to 95% and 70% to 96% respectively [7].  In another study involving 2944 previously 
unscreened South African women, Hybrid Capture I (HCI) and Hybrid Capture II (HCII) assays 
[34] were evaluated. The HCI was found to have the same sensitivity as the better specificity 
than either the HCI or HCII assay. These results suggest that HPV testing may be considered for 
primary cervical cancer screening in low-resource settings since it is easier to implement than 
cytology screening. Although it is anticipated that HPV DNA testing may reduce costs that are 
associated with unnecessary colposcopy, the current available HPV tests are still relatively 
expensive to be fully implemented in low-resource settings, there is need for laboratory 
infrastructure for processing. Also, currently available HPV tests require six hours to produce a 
result, resulting in multiple clinic visits for screening and treatment.  
More recently, rapid HPV test (careHPV) has been developed and promises to offer 
potential solutions to the limitations associated to the currently available HPV tests [35]. The test 
does not need a laboratory; it can be run in rural areas and mobile clinics. Single clinic visit may 
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be realized as test results are available within two and half hours. Qiao YL et al conducted a 
study in rural areas of China with careHPV and achieved a high sensitivity of 90% for 
identifying moderate or seveUHFHUYLFDOGLVHDVH&,1>35]. However, low specificity was 
recorded, limiting the efficacy of see-and-treat programs. There is a significant need for 
alternative solutions to support cervical cancer screening in settings where resources are limited.  
 
Visual inspection with acetic acid (VIA) has been explored in different developing countries as 
an alternative to the current paradigm [7, 31, 36, and 37].  VIA is a simple visual test, where the 
cervix is examined with the naked eye before and after application of acetic acid. Abnormal 
epithelium turns white (acetowhitening) after the application of acetic acid. VIA was evaluated 
in different studies, with more than 65,000 women from nine (9) different countries. The 
sensitivity of VIA varied from 67% to 79% and specificity ranged from 49% to 86% [38-43].  
VIA is inexpensive, requires minimal infrastructure and allows for immediate treatment, 
eliminating the need for histological analysis.  However, VIA is subjective, hence extensive 
training of the health-care provider is required, also consistent criteria for a suspicious lesion 
need to be precisely defined. In the hands of an expert, VIA can be effectively implemented, 
Jeronimo et al. substantially improved the diagnosis in a study involving almost 2000 women in 
Peru, with positivity rate dropping from 13.5% to 4% [31]. This was believed to have resulted 
from the experience acquired during these first few months in the study. Many other strategies 
including visual inspection with acetic acid and magnification (VIAM), visual inspection with 
/XJRO¶VLRGLGH9,/,KDYHEHHQH[SORUHGLQGHYHORSLQJFRXQWULHVZLWKSURPLVLQJUHVXOWVEXWDOO
these are subjective. For proper evaluation there is a great need for experienced personnel that 
are limited in these areas. 
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2.4 Optical Imaging Systems 
Recent developments in optics have led to new, portable imaging systems with the potential to 
image cells or tissue to reveal architectural and morphologic disease characteristics without need 
for tissue removal. Optical imaging has the capability to obtain and display both wide-field and 
highǦ resolution images of epithelial tissues in realǦ time [44]. Different optical technologies 
that detect relative changes in the way light interacts with tissue have been developed to aid in 
early cancer detection; these include reflectance imaging and spectroscopy, fluorescence imaging 
and spectroscopy, and Raman spectroscopy.  Supplementing conventional imaging with the use 
of polarized light, narrowband reflectance, and/or fluorescence imaging modes has been shown 
to improve sensitivity and specificity for several types of cancer, by reducing specular glare, 
enhancing vascular contrast, and detecting alterations in tissue fluorescence associated with the 
presence of disease. Digital optical imaging systems for cervical precancer have been developed 
using these principles [45-49].  
 
 
2.4.1 Role of optics in cancer 
Light scattering and absorption: Reflectance of light occurs when photons incident on 
tissue are back-scattered without a change in wavelength. Scattering in tissue arises due to 
differences in the refractive index between extracellular, cellular, and sub-cellular components. 
Angular measurements of elastic scattering from cells show nuclei and other cytoplasmic 
organelles cause scattering [50]. Normal epithelium scatters light differently from precancerous 
or cancerous epithelium; this is due to the increased nuclear size and optical density of the 
nucleus in an abnormal epithelium [51- 53]. Arifler, et al. found that scattering decreases in the 
stroma of dysplasia and is also dependent on depth in the epithelium, with scattering decreasing 
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in the intermediate layer compared to the superficial and basal layers [52]. Contrast agents like 
acetic acid have been found to increase light scattering from cervical cell nuclei [54]. Some 
studies have showed the mean scattering coefficient of precancerous tissue is as high as three 
times as that of normal epithelium [55, 56].  
Not all light is scattered, some is absorbed by chromophores present in the tissue. Hemoglobin is 
one of the major absorbers found in stromal vasculature, and plays a major role in light 
absorption. As the tissue becomes more dysplastic, microvessel density also increases greatly, 
and hemoglobin absorption may be increased [57]. 
 Fluorescence: Exciting tissue with ultraviolet (UV) or visible light can result in 
emission of 
fluorescent 
light at a 
longer 
wavelength. 
Tissue 
contains 
fluorophores 
such as 
crosslinks in 
collagen and 
elastin, cellular metabolism enzymes, and aromatic amino acids [58].  Fluorescence interrogation 
can help detect a range of biochemical changes. In normal tissue, collagen crosslinks result in 
 
Figure 5: Schematic diagram of the multispectral digital colposcope (MDC) [62]. 
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bright fluorescence in the stroma, but this bright fluorescence is greatly decreased in cervical 
precancer and cancers [59-61]. 
 
2.4.2 Wide-field Imaging Systems 
Wide-field imaging systems [62, 63] enable a relatively large field of view (50-100 mm) 
to be visualized at moderate resolution under conventional whiteǦlight illumination, as well as in 
fluorescence and polarized light modes.  Advances in wide-field, narrow-band reflectance 
imaging can also be utilized to enhance vascular contrast. Wide-field imaging can screen a 
relatively large tissue area with high sensitivity, highlighting regions suspicious for cancer.  
A number of researchers have embarked on studies investigating hyperspectral autofluorescence 
and reflectance imaging [64-67]. Orfanoudaki et al. evaluated a wide-field, multispectral 
reflectance imaging system in a study involving 123 women. The system improved the diagnosis 
as the false positive-diagnostic rate was found to be 1.7%, compared to 22% and 24.4% of 
conventional colposcopy and Pap test respectively [68]. Exciting tissue fluorescence with UV 
and blue wavelengths 440-470nm has been extensively studied and has shown great contrast 
between normal and precancerous tissue [62, 69].  Ferris et al investigated a hyperspectral wide-
field imaging system and found sensitivity of 97% and specificity of 70% [66]. Using the same 
system in a larger study of 572 women, DeSantis et al, found a sensitivity of 95.1% and a 
specificity of 55.2% for distinguishing between normal and high-grade precancer [67]. Similar 
results of a sensitivity of 92% and specificity of 50% were found in a different study involving 
604 women, using a different hyperspectral imaging system [64]. The USA FDA in 2006 
approved a trimodal imaging system termed; LUMATM. LumaTM uses 337nm UV nitrogen laser 
for fluorescence and two xenon flash lamps for reflectance. This system was evaluated in two 
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prospective, randomized controlled studies. A 22% gain in the true-positive rate from 193 
women study [70], similar results of about 26.5% gain in true-positive with only a 4% increase in 
false-positive rate versus that of colposcopy alone were obtained in a multicenter study involving 
2,299 women [65]. 
Our lab developed a Multispectral Digital Colposcope MDC [62] to measure multispectral 
autofluorescence and reflectance images of the cervix. The MDC (Fig. 5) is a modified standard 
colposcope with the ability to measure reflectance and fluorescence images. A video camera 
adapter was also incorporated. A color CCD camera was used to capture the images. Two 
excitation wavelengths 330 and 440nm showed the greatest diagnostic power relative to 
histology [62]. In a different study, the MDC achieved sensitivity and specificity of 79% and 
88% respectively in distinguishing high-grade precancer from low-grade precancer or normal 
tissue [63]. Roblyer et al developed a wide-field screening system for detection of oral neoplasia. 
This system is a multispectral imaging system capable of acquiring white light, cross-polarized, 
narrow-band reflectance and fluorescence [71].  Fluorescence excited at 405 nm was established 
as the best mode to discriminate between normal and dysplastic/cancerous oral tissue, with the 
normalized ratio of red-to-green fluorescence. Sensitivity and specificity of 100% and 91.4% 
respectively were achieved in a 67 patient study [72]. This system led to the development of a 
low-cost, portable system, termed the Portable Screening System (PS2). It consists of a 
commercially available surgical headlight system with loupes, LEDs, excitation and emission 
filters, a head-mounted CCD camera, and a compact lithium-ion battery. All components are 
battery powered. The PS2 acquires cross-polarized white light and fluorescence images [73]. The 
PS2 has been used in clinical pilot studies to assess the ability to help differentiate between 
normal, dysplastic and cancerous oral tissue [74]. In contrast to the images from the normal 
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tissue, the autofluorescence signal from dysplastic tissue shows a characteristic loss of 
autofluorescence. 
 
2.4.3 High-Resolution Imaging Systems 
Due to the limited spatial resolution of wide-field systems, researchers embarked on ways to 
image at higher 
spatial resolution. 
High-resolution 
optical imaging 
techniques have 
been used to 
observe changes 
in cells that 
indicate neoplastic 
transformation 
[75, 76]. Such 
indicators may be in the form of changes in the size and internal structure of the nucleus, the 
disorganization of cells, pleomorphism, and other cellular changes that require imaging with 
spatial resolution on the order of a few microns. High-resolution techniques have the potential to 
access indicators observed during pathological analysis such as cell morphology as well as 
epithelial architecture without the need for biopsy [77] therefore lowering costs or discomfort to 
the patient associated with traditional biopsy.  
 
 
 
 
 
 
 
 
 
 
Fig. 6: High-resolution imaging with the fiber-optic microendoscope. (a) Schematic 
diagram of the system layout. Ex / Em: fluorescence excitation and emission filters. (b, 
c) Microendoscope images of normal oral mucosa (b) and squamous cell carcinoma (c).  
(d)  Photograph of high resolution micro-endoscope (HRME). (e) Fiber-optic bundles to 
be placed in contact with tissue for imaging, 1 mm and 0.5 mm diameter, alongside a 
GRIN lens which can provide additional magnification. (f, g) corresponding 
histopathology from sites imaged in (b, c). 
(d) 
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Confocal microscopy has been used for a number of years for in vitro applications, but has 
recently been shown to be useful for the imaging of ex vivo biopsies and in vivo tissues [55, 75, 
78]. Tan et al used a confocal endomicroscopy in both reflectance and fluorescence modes, and 
achieved 97% sensitivity to detect CIN and 80% specificity for normal-CIN 1 and 93% 
specificity for CIN 2-CIN 3 [79].  Collier et al achieved sensitivity and specificity of more than 
90% by measuring the nuclear cytoplasmic (N/C) ratio [75]. Despite the advantages of confocal 
imaging, there are significant drawbacks that limit the potential applications. First, while 
miniaturization of confocal systems in recent years has created progressively smaller 
instrumentation, including a confocal endoscope, the optical and mechanical elements of these 
systems have generally limited the usefulness of this technique to easily accessible regions of the 
body [80-87].  Second, the technical complexity and high cost of confocal imaging systems has 
generally limited their application to high resource settings.  
Our lab has recently developed a new high resolution imaging system to address these 
limitations.  The system consists of a fiber-optic microendoscope (Fig. 6a) termed the high-
resolution microendosope (HRME); it is based on fluorescence imaging through a flexible, 1 mm 
diameter fiber-optic bundle (Fig. 6e) [88]. This unit, along with a laptop computer for image 
display, is completely battery-powered and can be transported within a briefcase to remote 
settings; fig. 6d shows the photograph of high-resolution micro-endoscope (HRME). This system 
is being evaluated in different pilot clinical studies; include the oral cavity [88] (Fig. 6), uterine 
cervix and esophagus [89]. These images were acquired on ex vivo tissue specimens, following 
topical application of 0.05% acriflavine solution. 
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Representative images and histopathology of normal oral mucosa (b, f) and squamous cell 
carcinoma (c, g) are shown in Fig. 6, demonstrating the ability of the microendoscope to image 
the distribution and density 
of cell nuclei within intact 
epithelium, following 
topical application of 
0.05% acriflavine solution.  
Acriflavine is a fluorescent 
dye, which can be used to 
selectively label cell nuclei 
due to its ability to bind to 
DNA. In Fig. 6b, nuclei of 
normal epithelium appear 
bright and sparsely distributed, while in Fig. 6c, nuclei appear crowded throughout the 800 nm 
diameter field-of-view; these features are seen in histology (Fig. 6f, g). 
 
2.5 Proflavine 
Proflavine is an acriflavine derivative, which has been used as a topical antiseptic. Proflavine is 
known to be able to label DNA in a nucleus of cells by intercalating between nucleic acid base 
pairs [90]. Although proflavine is not a molecular-specific agent, its binding to DNA 
distinguishes nuclei from the cytoplasm of the cell with nuclei appearing bright. High-resolution 
fluorescence imaging of this agent in tissue can give morphologic information such as the 
nuclear-to-cytoplasmic ratio which is an important parameter used in the histological diagnosis 
 
Figure 7: Excitation and emission spectrum of proflavine [91]. 
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of cancer [56]. Proflavine absorbs strongly at 445 nm, and it emits light with a peak around 510 
nm [91] as shown in Figure 7.  Topical use of proflavine has a long history of reported safe use 
in humans [92, 93]; it has been used extensively as a topical antiseptic [94]. I used proflavine at a 
relatively small dose (0.01%), as part of a one-time screening procedure to stain epithelial cells 
of the cervix that will naturally exfoliate in a fairly short time. Our lab has obtained IRB 
approval and an IND from the FDA to use to topical proflavine as a contrast agent to aid in the 
HDUO\GHWHFWLRQRIG\VSODVLDLQ%DUUHWW¶VHVRSKDJXVDQGLQWKHRUDOPXFRVD:HKDYHDOVR
obtained IRB approval for topical use in the cervix. 
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3. HIGH-RESOLUTION MICROENDOSCOPE FOR THE DETECTION OF CERVICAL 
NEOPLASIA IN LOW-RESOURCE SETTINGS 
 
The contents of this chapter have been published in the following journal article: Quinn MK, Bubi TC, Pierce MC, 
Kayembe MK, Ramogola-Masire D, et al. (2012) High-Resolution Microendoscopy for the Detection of Cervical 
Neoplasia in Low-Resource Settings. PLoS ONE 7(9): e44924. doi:10.1371/journal.pone.0044924 
 
 
 
Abstract: Cervical cancer is the second leading cause of cancer death among women in 
developing countries. Developing countries often lack infrastructure, cytotechnologists, 
and pathologists necessary to implement current screening tools. Due to their low cost 
and ease of interpretation at the point-of-care, optical imaging technologies may serve as 
an appropriate solution for cervical cancer screening in low resource settings. We have 
developed a high-resolution optical imaging system, the High Resolution 
Microendoscope (HRME), which can be used to interrogate clinically suspicious areas 
with subcellular spatial resolution, revealing changes in nuclear to cytoplasmic area ratio. 
,Q WKLV SLORW VWXG\ FDUULHG RXW DW WKH ZRPHQ¶V FOLQLF RI 3ULQFHVV 0DULQD +RVSLWDO LQ
Botswana, 52 unique sites were imaged in 26 patients, and the results were compared to 
histopathology as a reference standard. Quantitative high-resolution imaging achieved a 
sensitivity and specificity of 86% and 87%, respectively, in differentiating neoplastic 
($CIN 2) tissue from non-neoplastic tissue. These results suggest the potential promise of 
HRME to assist in the detection of cervical neoplasia in low-resource settings. 
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3.1 Introduction 
Cervical cancer is the third most common type of cancer among women worldwide. In 2008, 
there were an estimated 530,000 new cases and more than 275,000 deaths due to cervical cancer. 
Over 85% of new cases of cervical cancer and deaths due to cervical cancer occur in developing 
countries where screening programs for early detection are either inadequate or unavailable [1]. 
In the United States and many other high-resource countries, organized screening programs 
based on the Pap (Papanicolaou) smear and human papillomavirus (HPV) tests enable early 
diagnosis and treatment of precancerous lesions. An abnormal Pap smear test or HPV test is 
followed by colposcopy. If abnormalities are evident under colposcopy, a biopsy is required to 
confirm disease before treatment. The widespread use of Pap smears, colposcopy, biopsy, and 
treatment of pre-cancerous lesions has led to dramatic reductions in the incidence and mortality 
of cervical cancer in the United States [95]. However, this process requires multiple patient visits 
and highly trained personnel to read cytology and biopsy results. In resource-constrained 
settings, the increased risk of patient loss to follow-up and lack of trained personnel and 
laboratories often make this screening paradigm ineffective. HPV testing has been explored in 
developing countries and the available data have demonstrated the potential of HPV testing to 
reduce both the mortality and long term risk of cervical cancer [96]. However, currently 
available HPV tests require six hours to produce a result, necessitating multiple visits for 
screening and treatment. More recently, rapid HPV tests have emerged which may offer a 
potential solution, but are yet to become commercially available [35]. Alternative early cervical 
cancer detection methods that are accurate, low cost, and that allow immediate diagnosis and 
treatment in a single visit are crucial for low-resource countries [7]. Visual inspection with acetic 
acid (VIA) is the most widely available screening modality in developing countries. This is a 
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simple visual test, in which the cervix is examined with the naked eye before and after 
application of 3 to 5% acetic acid (vinegar). Upon application of the acetic acid, suspicious areas 
turn white. VIA has been explored in various developing countries as an alternative to cytology, 
and has shown promising results in detecting high-grade dysplasia or invasive carcinomas 
[43,97]. Although not as extensively used as VIA, visual inspection with /XJRO¶VLRGLQH9,/,
has shown promising results compared to both Pap smear and VIA. In a multicenter study in 
several developing countries involving 56,939 women, the sensitivity of VIA varied from 67-
79% and specificity ranged from 49%-86%, while the sensitivity and specificity of VILI varied 
from 76%±97% and 73%±92%, respectively [43]. VIA and VILI are inexpensive, require 
minimal infrastructure, allow for immediate treatment, and eliminate the need for a laboratory. 
Despite the advantages of 
VIA and VILI over cytology, these tests are subjective, requiring extensive and ongoing training 
of health-care providers, and are frequently associated with low specificity, which can result in 
significant overtreatment. 
As an alternative to visual examination of the cervix, high-resolution fiber optic microscopes are 
now available which facilitate direct visualization of neoplastic indicators such as elevated 
nuclear to cytoplasmic area ratio, nuclear crowding, and pleomorphic nuclei. These indicators 
are conventionally only observed during cytologic or histologic analysis following an invasive 
biopsy. Vital dyes can provide high optical contrast if applied topically. For example, proflavine, 
a fluorescent DNA label, distinguishes nuclei from the cytoplasm of the cell with nuclei 
appearing bright. Proflavine has peak absorbance at 445 nm and a peak emission at 510 nm. 
High-resolution fluorescence imaging of this agent in tissue can yield morphologic information 
such as the nuclear-to-cytoplasmic ratio which is an important parameter used in the histological 
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diagnosis of cancer. It has a long history of safe clinical use as a topical antiseptic [93,92], and is 
a component of acriflavine, which has been used in clinical imaging studies of the 
gastrointestinal tract and cervix [98,79]. 
 
 
Figure 8: Photograph of high-resolution micro-endoscope (HRME) 
 
Due to their low cost and ease of interpretation at the point-of-care, high resolution 
optical imaging technologies may serve as an appropriate solution for cervical cancer screening 
in low resource settings [76]. We recently developed a high-resolution microendoscope (HRME) 
to address the limitations of conventional methods of cervical cancer screening. The HRME has 
been evaluated in pilot studies of oral and esophageal precancer diagnosis [99±101]. In these 
studies, proflavine is applied topically to the squamous epithelium, and the area is interrogated 
with a fiber-optic bundle. Changes in cell morphology and epithelial architecture can be 
visualized in real time on a laptop computer. The objective of this study was to evaluate the 
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ability of this high-resolution microendoscope to identify cervical neoplasia in patients at the 
ZRPHQ¶VFOLQLFDW3ULQFHVV0DULQD+RVSLWDOLQ Botswana. Images were acquired from 52 sites in 
26 patients. The images acquired by the microendoscope were assessed by both visual inspection 
by two expert observers and quantitative analysis to discriminate neoplastic (CIN 2) from non-
neoplastic cervical tissue. Results were compared to histopathology as the reference standard. 
 
 
 
 
 
 
 
 
 
 
Table 1. Number of sites imaged by HRME, grouped according to histopathology diagnosis. 
 
 
3.2 Materials and Methods 
3.2.1 Instrumentation 
Images were acquired using a custom designed, low cost high-resolution microendoscope 
(HRME); this system has been described in detail previously [102]. Briefly, the HRME is a fiber 
optic fluorescence microscope, which can acquire images of tissue with sub-cellular resolution at 
video-rate. As shown in Fig. 8, the HRME consists of a coherent, flexible 1 mm diameter fiber 
Diagnostic 
Category 
Histopathology 
Diagnosis 
Number of Sites 
Imaged 
Normal/Benign 
Normal 5 
Inflammation 7 
LGSIL 
HPV Effect 11 
CIN I 7 
HGSIL 
CIN 2 2 
CIN 3 12 
Total Number of Sites Imaged 44 
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bundle (Sumitomo, IGN-08/30) coupled to a light source and a digital CCD camera. Light from a 
blue LED with peak wavelength centered at 455 nm (Thorlabs, FB450-40) provides illumination; 
fluorescence emission from the tissue is collected by the bundle, transmitted through a 475 nm 
dichroic mirror (Chroma, 475DCXRU), and focused onto an optical sensor of the CCD camera 
(Point Grey Research, GRAS-14S5C-M) by an objective lens (106/0.25) and a 150 mm tube 
lens. Images are transferred to a laptop via IEEE-1394 (Firewire) cable. The field of view of the 
HRME is 720 mm in diameter, and the lateral spatial resolution is approximately 4 mm. 
 
3.2.2 Clinical Measurements 
Women attending a colposcopy clinic on the basis of an abnormal Pap smear were eligible to 
participate in the study if they were at least 18 years of age and not pregnant. A health care 
provider described the procedure to eligible patients; patients who agreed to participate were 
provided with and signed forms indicating informed consent and authorization. Study 
participation included colposcopic examination of the vulva, vagina, and cervix using 3% acetic 
acid. Abnormal cervical lesions in the transformation zone were identified and noted by the 
study physician, in accordance with routine patient care. Each lesion was described and 
classified by the study physician as clinically high grade, clinically low grade, or clinically 
normal using the Reid Colposcopic Index [103]. Following routine colposcopic examination, a 
solution of proflavine hemisulfate (0.01% w/v in sterile phosphate buffered saline) was topically 
applied to the cervix with a cotton swab. Following application of proflavine, the HRME was 
advanced through the speculum and placed in gentle contact with the cervix. Three second 
movies were obtained by the HRME from up to two clinically abnormal cervical sites and one 
clinically normal cervical site in the transformation zone. Following optical measurements, all 
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sites interrogated with the HRME probe were biopsied and submitted for routine histopathologic 
analysis. A single pathologist who was blinded to the results of the optical imaging read biopsies. 
Diagnostic classification categories included normal, inflammation, HPV effect, grade 1 cervical 
intraepithelial neoplasia (CIN 1), grade 2 cervical intraepithelial neoplasia (CIN 2), and grade 3 
cervical intraepithelial neoplasia (CIN 3) using standard histopathologic criteria [104]. 
Squamous metaplasia was considered a normal result. No cases of carcinoma in situ (CIS) or 
squamous cell carcinoma (SCC) were observed in this study. Low-grade dysplasia includes HPV 
effect and CIN 1, and high grade dysplasia includes CIN 2 and CIN 3. Normal/benign results 
included inflammation. For purposes of data analysis, neoplastic tissue was classified as high 
grade dysplasia, and all other diagnoses were considered to be non-neoplastic. 
 
3.2.3 Data Analysis 
For each HRME movie, one representative frame was chosen which minimalized motion artifact 
and obstruction of the field of view due to cellular debris. The user selecting the frames was 
blinded to all diagnostic information. The resultant HRME images were reviewed for quality 
control by a reviewer blinded to all diagnostic information. Images were discarded if more than 
50% of the field of view was out of focus, contained evidence of motion artifact, or contained 
significant debris. HRME images that passed quality control and had a corresponding 
histopathologic diagnosis were analyzed in two ways. 
First, images were reviewed by two expert observers, who had each previously reviewed 
HRME images from more than 50 cases of normal and neoplastic tissues. HRME images passing 
quality control were presented to each reviewer in randomized order; reviewers were instructed 
to classify each image as non-neoplastic or neoplastic. The sensitivity and specificity of 
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qualitative analysis was calculated for each reviewer using histopathologic diagnosis as the 
reference standard. 
Second, image analysis software was used to analyze each HRME image which passed 
quality control to calculate quantitative image features. Analysis focused on assessment of 
nuclear size, since changes in nuclear size and nuclear-to-cytoplasmic ratio are hallmark 
histopathologic features of cervical precancer [105]. A reviewer, blinded to the histopathologic 
diagnosis, first manually selected a region of interest (ROI) for quantitative analysis. The ROI 
was selected to include regions with visible nuclei and to exclude regions with evidence of 
motion artifact, image saturation, or debris. Following selection of the ROI from an HRME 
image, image contrast was adjusted using a contrast-limited adaptive histogram equalization, and 
median filtering was applied to remove the background pattern associated with the structure of 
the fiber bundle. Each processed gray-scale image was then converted to a binary image using a 
threshold value. A reviewer, again blinded to the histopathologic diagnosis, reviewed the binary 
images and adjusted the threshold value to ensure that nuclei were segmented appropriately 
based on visual assessment. Binary images were then processed to remove all objects with fewer 
than 50 pixels (assumed to be noise) and more than 1500 pixels (assumed to be debris). Finally, 
for each image the mean nuclear to cytoplasmic area (N/C) ratio was calculated by dividing the 
total nuclear area by the total cytoplasmic area within the ROI. 
3.2.4 Ethics Statement 
The study protocol was reviewed and approved by the Institutional Review Board at Rice 
University and the Health Research Division Office of the Botswana Ministry of Health. 
Written informed consent documents were available in both English and the local national 
language (Setswana). All patients involved in the study gave written informed consent. 
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Results 
HRME images were acquired from 52 sites in 26 patients. Images from 8 sites were excluded 
from further analysis because they did not pass quality control criteria outlined above. The 
rejection of the 8 sites eliminated all data from one subject. For this subject, the two movies 
collected were both out of focus because the distal tip of the probe was not in contact with the 
cervical epithelium. Table 1 summarizes the histopathologic diagnoses of the remaining 44 sites. 
The majority of patients in the study were human immunodeficiency virus (HIV) infected, which 
has been correlated with a high incidence of intraepithelial lesions [106]. 
Figure 9 shows typical HRME images of clinically and histopathologically normal (a±c) 
and neoplastic (d±f) cervical tissues. The top row shows a colposcopic photograph of the cervix; 
the white arrow indicates the clinically normal site where the HRME probe was placed. The 
corresponding HRME image shows small, regularly spaced nuclei. Both expert reviewers 
considered this image qualitatively non-neoplastic, which was consistent with the 
histopathologic diagnosis of HPV effect. The bottom row shows a colposcopic photograph 
indicating a clinically abnormal thick aceto-white lesion (white arrow). The HRME image 
obtained from this site shows large, crowded, pleomorphic nuclei. The image was considered 
qualitatively neoplastic by both expert observers, which was consistent with the histopathologic 
diagnosis of CIN 3. 
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Figure 9. Comparison of colposcopic appearance, HRME images, and histologic diagnosis. The 
top row shows images obtained from a clinically normal region of the cervix. The white arrow in 
the colposcopic image (a) indicates the area imaged with the HRME. The HRME image (b) shows 
small, uniformly spaced nuclei, and was considered non-neoplastic by both subjective expert 
observers, which is consistent with histopathology indicating HPV effect (c). The bottom row 
shows images from a clinically abnormal region of the cervix. The white arrow in the colposcopic 
image (d) indicates a region with a clinical impression of high grade disease. The corresponding 
HRME image (e) shows large, pleomorphic, crowded nuclei and was considered neoplastic by 
both subjective expert observers, which is consistent with histopathology indicating CIN3 (f). 
 
Figure 10 shows HRME images obtained from a case in which the colposcopic 
impression did not agree with the histopathologic diagnosis. The colposcopic photograph shows 
a warty lesion (white arrow) which was classified as clinically high grade disease according to 
the Reid Colposcopic Index. The HRME image obtained from this site showed small nuclei, 
characteristic of normal epithelium. The expert reviewers categorized this image as non-
neoplastic. This was consistent with the histopathologic diagnosis of HPV effect. 
(c) 
(f) 
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 Qualitative diagnoses by the expert HRME observers for all 44 sites were compared with 
histopathologic diagnosis to calculate sensitivity and specificity. Observer #1 classified the 
images with a sensitivity and specificity of 86% and 70% respectively. Observer #2 classified the 
images with a sensitivity and specificity of 93% and 73% respectively. 
 
 
Figure 10. Comparison of colposcopic appearance, HRME images, and histologic diagnosis in a 
case where colposcopic impression did not agree with histopathologic diagnosis. The white arrow 
in the colposcopic image (a) indicates the area imaged with the HRME; the clinical impression of 
this warty looking lesion was high grade disease according to the Reid Colposcopic Index. The 
HRME image (b) shows small, uniformly spaced nuclei. This image was considered qualitatively 
non-neoplastic by both subjective expert observers, which is consistent with the histologic image 
indicating HPV effect (c). 
 
Quantitative morphometric image analysis was next performed; 
Figure 4 illustrates results from representative HRME images of non-neoplastic and neoplastic 
tissues. In each image, the user defined ROI is outlined in green; within this ROI, the 
automatically segmented nuclei are outlined in red. ROI size did not vary significantly from 
neoplastic images to non-neoplastic LPDJHV6WXGHQW¶VW-test, p.0.5). Figure 11a shows an HRME 
image from a site histopathologically diagnosed as HPV effect; the N/C ratio was 0.08. In 
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contrast, Fig. 11b shows an HRME image from a site diagnosed as CIN 3 with an N/C ratio of 
0.22. 
 
Figure 11. HRME images were analyzed to calculate the average nuclear to cytoplasmic (N/C) 
area ratio. A region of interest (green) was defined by the user to select regions of the image with 
visually observable nuclei. Within this region, a computer program segmented nuclei and 
calculated the N/C area ratio. Representative images showing a site diagnosed as HPV with an 
N/C ratio of 0.08 (a) and site diagnosed as CIN 3 with an N/C ratio of 0.22 (b) are shown. 
 
To assess whether differences in the N/C ratio as measured from HRME images correlated with 
histopathologic diagnosis, we grouped sites by histopathologic diagnosis and calculated the mean 
of the N/C ratio (Fig. 12). Results show that the average N/C ratio increases with increasing 
grade of neoplasia; the mean N/C ratio of sites diagnosed as high grade dysplasia was 
significantly higher WKDQWKRVHGLDJQRVHGDVQRUPDOEHQLJQ6WXGHQW¶VW-test, p = 2.061025) and 
WKRVHGLDJQRVHGDVORZJUDGH6WXGHQW¶VW-test, p = 1.961025). 
Figure 13 shows a scatter plot indicating the N/C ratio vs. histopathologic diagnosis for 
each of the 44 sites measured in this study. We explored whether this parameter could be used to 
classify sites as neoplastic (high grade dysplasia) or non-neoplastic (normal/benign or low grade 
dysplasia). Using a simple cut-off where sites with an N/C ratio greater than 0.163 were 
diagnosed as neoplastic and sites with an N/C ratio of less than 0.163 were classified as non 
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neoplastic correctly classified 12 of 14 sites with a histopathologic diagnosis of high grade, 16 of 
18 sites with a histopathologic diagnosis of low grade, and 10 of 12 sites with a histopathologic 
diagnosis of normal/benign. 
 
Figure 12. The average N/C ratio versus histopathologic diagnosis by diagnostic category. The 
average N/C ratio of sites diagnosed as high grade dysplasia was significantly higher than those 
GLDJQRVHG DV QRUPDOEHQLJQ 6WXGHQW¶V W-test, p = 2.0E- DQG ORZ JUDGHG\VSODVLD 6WXGHQW¶V W-
test, p = 1.9E-5). Error bars indicate standard error. 
 
 
The receiver operator characteristic (ROC) curve for a diagnostic algorithm based on the N/C 
ratio is shown in Fig. 14. The Q-point indicated on the figure corresponds to the cut-off value 
shown in Fig. 13, and corresponds to a sensitivity of 86% and a specificity of 87%. Figure 14 
also shows the accuracy of visual interpretation of the HRME images by two observers relative 
to the reference standard of histopathology. For both observers, the accuracy of visual image 
interpretation lies near the ROC curve for quantitative image interpretation. For comparison, the 
sensitivity and specificity of clinical colposcopic impression for the same sites were 64% and 
83%, respectively when clinically low-grade lesions were considered non-neoplastic. 
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Figure 13. Scatter plot of N/C ratio for all samples, broken down by histopathologic diagnosis. 
The dotted line indicates a threshold at 0.163 with a sensitivity of 86% and a specificity of 87% 
for separating samples diagnosed as high grade dysplasia from samples diagnosed as low grade 
dysplasia or normal/benign. 
 
 
Discussion 
This study suggests that high-resolution microendoscopy shows promise to improve cervical 
cancer screening in resource-constrained settings. In this pilot study, both the sensitivity and 
specificity of HRME based detection were higher than that of colposcopic impression. While 
encouraging, our study has a number of limitations. First, it was a pilot study involving only 52 
sites in 26 patients. A larger, prospective study is required to confirm the results. Second, all 
HRME images were acquired from colposcopically suspicious and normal areas in the 
transformation zone. We have not characterized HRME images of endocervical tissue to 
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determine whether they may be a potential source of error. Although all data in this study was 
taken from the transformation zone of the cervix as identified by the physician, three biopsies 
were noted to contain predominantly columnar epithelium by pathology. Further research is 
necessary to identify the differences between HRME images of dysplastic squamous epithelium, 
normal columnar epithelium, and dysplastic columnar epithelium. 
 
Figure 14. Receiver operator characteristic curve for the algorithm shown in Figure 6. The star 
indicates the Q-point, with a sensitivity of 86% and a specificity of 87%. The performance of 
visual interpretation of HRME images by two observers is indicated and falls along the ROC 
curve for automated image analysis. For comparison, the sensitivity and specificity of clinical 
colposcopic impression for the same sites were 64% and 83%, respectively. 
 
High-resolution imaging offers a number of potential advantages as a screening tool. 
Studies of VIA have shown a wide range of resulting sensitivities and specificities. A metastudy 
of VIA, ZKLFK LQFOXGHG 6DQNDUDQDUD\DQDQ¶V PXOWLFHQWHU VWXG\ UHYHDOHG sensitivities ranging 
from 41%±92% and specificities ranging from 49%±98% [107]. This significant variation in 
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accuracy calls for additional measures to maintain consistency of diagnoses. The HRME system 
could potentially act as additional test to VIA and VILI screening systems. 
When VIA and VILI screening systems refer patients for additional treatment, providers 
in low resource settings can choose to screen and SURYLGHFDUHLQRQHYLVLW7KHµµVHHDQGWUHDW¶¶
system eliminates biopsies to confirm disease in visible lesions before a loop electrosurgical 
excision procedure (LEEP) or cautery [108]. Our results suggest that the HRME shows promise 
as a reliable alternative to a biopsy at this second line of care in resource-constrained areas. In 
particular, the high specificity of the HRME results indicates that high-resolution 
microendoscopy could potentially lower the number of overtreated lesions. 
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4. HRME VALIDATION PAPER 
 
4.1 INTRODUCTION 
Despite being almost 100% curable when detected early [6], cervical cancer continues to 
be a major health problem for women in developing countries. In 2008, there were an estimated 
235,000 deaths in developing countries due to cervical cancer compared to just over 41,000 
deaths in developed countries [1]. In 2002, cervical cancer incidence and mortality rates were 
nearly 6 and 15 times higher in sub Saharan Africa than in North America [2]. Parkin et al 
estimate that by the year 2020, 90% of the mortality of cervical cancer will occur in developing 
countries if no major interventions are carried out [2].   
Disparities in the incidence and mortality of cervical cancer between developed and 
developing countries arise mainly due to the uneven distribution of healthcare resources. In 
developed countries where organized screening and early detection programs have been 
implemented, the incidence and mortality rates are greatly reduced. This reduction is largely 
credited to the use of Papanicolaou (Pap) smear screening, followed by colposcopic diagnosis, 
and treatment of neoplastic lesions [109]. However, this process requires multiple patient visits 
to the clinic and highly trained personnel to read cytology and pathology, making it difficult to 
implement in resource-limited settings. 
A number of cost-effective screening techniques have been investigated for use in low-
UHVRXUFHFRXQWULHV LQFOXGLQJYLVXDO LQVSHFWLRQXVLQJHLWKHUDFHWLFDFLG9,$RU/XJRO¶VLRGLQH
(VILI) [±7, 36,43, 110]. Although encouraging results have been reported, these tests have low 
specificities, resulting in high rates of overtreatment, which wastes scarce resources.  
Since cervical neoplasia is caused by persistent infection of the cervix with human 
papillomavirus (HPV), HPV DNA testing has been explored as an alternative screening 
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approach. In most cases, HPV testing demonstrated similar or better sensitivities compared to 
VIA and Pap smear screening [±7, 96, 110]; however, currently available HPV tests require a 
fully functioning laboratory and test results are not immediately available, making widespread 
implementation difficult in developing countries.  
High-resolution optical imaging has also been investigated as alternative approach to 
improve early detection. Optical images of cervical epithelium can be obtained in real time 
without the need for biopsy; resolution is sufficient to visualize changes in cell morphology and 
epithelial architecture that are characteristic of cervical neoplasia. Both confocal reflectance and 
fluorescence microscopy have shown promising results to aid in early detection of cervical 
neoplasia in ex vivo and in vivo studies [45, 56, 75, 79]. Tan et al [79] used in vivo confocal 
endomicroscopy in reflectance (following application of 6% acetic acid) and fluorescence 
(following application of acriflavine) modes, demonstrating the ability of confocal microscopy to 
visualize nuclear morphology in the cervical epithelium; the resulting images could be used to 
identify cervical neoplasia with a sensitivity and specificity of 97% and 93%, respectively. While 
promising, the technical complexity and high cost of confocal imaging systems have limited their 
use to high resource settings. 
Recently, we developed a new high resolution optical imaging system with promise for in 
vivo detection of cervical neoplasia in low resource settings; the high-resolution microendoscope 
(HRME) is a battery powered, fiber optic fluorescence which can obtain images of epithelial 
tissue at 15 frames per second with a spatial resolution of 4 um and a field of view of 750 um.  
The affordable system can be transported in a briefcase for use in remote settings.  
Several pilot studies have been carried out using the HRME to explore the ability to 
discriminate neoplastic and non-neoplastic tissues in the oral cavity [99] and breast [112].  The 
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HRME was used to acquire in vivo images of cervical epithelium in Princess Marina Hospital in 
Botswana, a low-resource setting with a high prevalence of cervical cancer [111]. In that study, 
44 sites were imaged and an image analysis algorithm was developed to distinguish neoplastic 
and non-neoplastic tissue. Using only the mean nuclear to cytoplasmic area ratio, the algorithm 
achieved a sensitivity of 86% and specificity of 87% compared to the reference standard of 
histology.  To more objectively evaluate the potential utility of this approach requires that the 
algorithm performance be evaluated with an independent data set.  The goal of this study was to 
test the reliability and reproducibility of these results using the same algorithm in the same low-
resource setting. A total of 128 sites from 60 subjects were imaged; HRME images from each 
measured site were analyzed quantitatively using the same image analysis procedure to 
discriminate neoplastic (HGSIL or cancer) from non-neoplastic tissue (normal/benign or 
LGSIL). Results were compared to the gold standard of histopathology. 
 
4.2 MATERIALS AND METHODS 
4.2.1 Study Population 
This study was conducted at Princess Marina Hospital (PMH), Gaborone, Botswana.  The 
study was reviewed and approved by the Institutional Review Boards at PMH and at Rice 
University. Patients referred for colposcopy because of an abnormal 3DSVPHDUDJHG\HDUV
and not pregnant were eligible to participate in the study. The procedure was fully described by 
the research nurse and a signed informed consent obtained from all study participants.  
Patients underwent standard-of-care colposcopic examination, during which the study 
physician identified, described and classified the abnormal cervical lesions using standard 
clinical criteria [103]. Following colposcopy, a solution of proflavine hemisulfate (Sigma-
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Aldrich, P2508) dissolved in sterile phosphate buffered saline at a concentration of 0.01% (w/v) 
was topically applied to the cervix with a cotton swab. Immediately after application of 
proflavine, the HRME probe was placed in gentle contact with a site in the transformation zone 
and three second movies were recorded. Several sites in each patient were selected by the 
clinician for HRME measurement, including up to two clinically suspicious lesions and one site 
with a normal clinical appearance. Upon completion of the optical measurements, biopsy 
specimens were collected from the measured sites and then submitted for routine histopathologic 
HYDOXDWLRQ 7KH VWXG\ SDWKRORJLVW¶V GLDJQRVHV ZHUH FDWHJRUL]HG DV QRUPDO LQIODPPDWLRQ
squamous metaplasia, HPV infection, grade 1 cervical intraepithelial neoplasia (CIN 1), grade 2 
cervical intraepithelial neoplasia (CIN 2), and grade 3 cervical intraepithelial neoplasia (CIN 3). 
Low grade dysplasia included HPV effect and CIN1 and high grade dysplasia included CIN2 and 
CIN3. Normal, inflammation squamous metaplasia, and low-grade dysplasia were defined as 
non-neoplastic. High-grade dysplasia was defined as neoplastic tissue. 
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Table 2: Number of sites imaged by HRME, grouped according to histopathology diagnosis.  
 
4.2.2 Data analysis 
Images were visually evaluated for quality control by two observers who were blinded to 
the histologic diagnosis. Images were discarded if more than 50% of the field of view appeared 
to be out of focus and contained significant debris, if there was evidence of motion artifact, or if 
it appeared WKDWWKH¿EHU-optic probe was not in contact with the tissue..  
  Image analysis software was written (Matlab R2010b) to quantify image features 
associated with cervical precancer. This software has been described in detail previously [111]. 
Briefly, a region of interest (ROI) was selected from each image by an observer who was blinded 
Diagnostic 
Category 
Histopathology 
Diagnosis 
Number of Sites 
Imaged 
  
 
 
 
 
 
 N
on
-n
eopla
stic
 
Normal/Benign 
Normal 9 
Inflammation 7 
Low Grade 
Dysplasia 
HPV Effect 33 
CIN 1 8 
 N
eopla
stic
 
High Grade 
Dysplasia 
CIN 2 8 
CIN 3 34 
Total  
 
99 
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to both clinical impression and histologic diagnosis; the ROI was chosen from areas of the image 
illustrating cellular detail, avoiding regions with evidence of motion artifact, out of focus, or 
debris. The ROI from each image was then analyzed as follows. First, image contrast was 
adjusted and the ROI was median filtered to eliminate the structure of the fiber bundle. The 
resulting image was then converted to a binary image and a threshold applied to segment nuclei. 
Morphologic processing was applied to remove noise from the image; segmented regions that 
contained IHZHUWKDQSL[HOVZHUHUHPRYHGDVWKH\ZHUHDVVXPHGWREH³QRLVH´ZKLOHREMHFWV
that contained more than 1500 pixels were removed because they were thought to be debris. 
Finally, the number of pixels corresponding to nuclei were summed and divided by the total 
number of pixels in the ROI (minus nuclei), to yield the nuclear-to-cytoplasmic area (N/C) ratio. 
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Figure 15: Typical colposcopic and HRME images. The top row illustrates images obtained from 
a clinically normal region of the cervix. (a) The black arrow in the colposcopic image indicates the 
area imaged with the HRME. (b) The HRME image shows small, uniformly spaced nuclei, 
consistent with the histopathology diagnosis of pathologic changes.  The bottom row shows 
images from a clinically abnormal region of the cervix.  (c) The black arrow in the colposcopic 
image indicates a region with a clinical impression of high grade disease imaged by HRME. (d) 
The HRME image shows large, pleomorphic, crowded nuclei, and was consistent with the 
histopathology diagnosis of CIN 3. 
 
 
4.3 RESULTS  
 
A total of 128 unique sites from 60 subjects were imaged and biopsied. Images from 13 
of these sites failed the quality control as described above. Images from another thirteen sites 
were not included because they were acquired from columnar epithelium, and 3 sites were 
discarded because of inconclusive pathology diagnosis. The remaining 99 sites were grouped 
according to histopathology diagnosis (Table2). 
100µm 
100µm 
(a) (b) 
(c) (d) 
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Figure 15 shows representative colposcopic images and HRME images from two patients 
in the study. The top row (a, b) illustrates images obtained from a clinically normal region of the 
cervix. The black arrow in the colposcopic image indicates the area imaged with the HRME. The 
resulting HRME image shows small, bright nuclei with dark cytoplasm and relatively large and 
evenly spaced internuclear separation, which is consistent with the histopathology diagnosis of 
normal.  In contrast, images of a clinically suspicious site are shown in the bottom row (c, d). 
The black arrow in the colposcopic image indicates a clinically suspicious region with a thick 
aceto-white lesion where the HRME image was acquired.  The resulting HRME image shows a 
remarkable increase in nuclear-to-cytoplasmic ratio and crowding of nuclei. This site was 
diagnosed as CIN 3 by histopathology. 
Figure 16a shows a scatter plot of the previously pubished nuclear-to-cytoplasmic ratio 
calculated from the training set [111]. The horizontal dashed line represents the discrimination 
threshold at 0.163 determined in the previous study.    Figure 16b shows a scatter plot of the 
nuclear-to-cytoplasmic ratio calculated from each of the 99 sites imaged in this validation study. 
The horizontal dashed line indicated the same threshold used for the training set.  Figure 17 
shows the corresponding receiver operator characteristic curves.  At the same threshold as in 
Figure 16, the algorithm yields sensitivities and specificities of 86% and 87% for the training set 
and 90% and 85% for the validation set, respectively. The sensitivity and specificity of clinical 
impression for the validation set for the same sites were 55% and 88%, respectively. 
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Figure 16: Scatter plot of N/C ratio for sites in the training and validation sets, broken down by 
histpathologic diagnosis.  (a) N/C ratio of the 44 sites in the training set (previously published in 
[16]). (b) N/C ratio of the 99 sites in the validation set. The horizontal dashed line in (a) indicates 
the discrimination threshold; sites with an N/C ratio >0.163 were diagnosed as neoplastic. This 
threshold yields a sensitivity of 86% and a specificity of 87% relative to the gold standard of 
histology. The same threshold was applied to the validation set and yielded a sensitivity of 90% 
and specificity 85% relative to histology. 
 
4.4 DISCUSION  
The purpose of this study was to assess the reliability and reproducibility of a previously 
developed image analysis algorithm to determine whether sites imaged with a high resolution 
microendoscope are neoplastic or non-neoplastic.   In vivo digital images of the cervix were 
acquired from 128 unique sites in 60 patients.  As in the previously acquired training set, images 
from tissue with high-grade precancer exhibited higher N/C ratio than benign tissue or tissue 
with low-grade precancer. Images could be accurately classified by simply calculating the N/C 
ratio and using a simple threshold; in this validation set, the algorithm discriminated between 
neoplastic and non-neoplastic tissue with a sensitivity of 90% and specificity of 85%. These 
results are very comparable to those that we previously reported in the training set [111]. In both 
cases, automated analysis of HRME images results in significantly better sensitivity than that of 
clinical impression. 
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Figure 17: Receiver operator characteristic curve for the algorithm shown in Figure 2.  The grey 
curve represents the training set; the Q-point corresponds to a sensitivity of 86% and a specificity 
of 87%.  The black curve represents the validation set; the Q-point corresponds to a sensitivity of 
90% and a specificity of 85%. The sensitivity and specificity of clinical colposcopic impression 
for the validation set for the same sites were 55% and 88%, respectively. 
 
The findings of this study suggest that HRME imaging may have potential to improve 
real-time, noninvasive assessment of cervical pre-cancer in low-resource countries. HRME 
images can be acquired and interpreted at point-of-care, potentially reducing the cost and 
infrastructure needed to take, process, and read biopsies. In addition, see-and-treat programs are 
limited by the low specificity of HPV tests or VIA. The high specificity of HRME imaging 
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presents an opportunity to address these limitations; it may be combined with these tests to 
enhance the see-and-treat programs. 
Our study has a number of limitations. First, the small field-of-view of the HRME makes 
surveillance of the entire cervix impractical. The device could be used in conjunction wide-field 
imaging systems to rapidly image the entire cervix and identify regions which are suspicious for 
neoplasia, and can then be interrogated using the HRME to confirm the presence or absence of 
neoplasia. Second, we excluded thirteen images from this study because they were acquired from 
columnar epithelium. Further improvements are needed to the image analysis algorithm to 
analyze images of columnar epithelium. 
In summary, we have developed a low-cost, portable high-resolution imaging device capable of 
accessing indicators observed during pathological analysis such as cell morphology without the 
need for biopsy. Coupled with simple quantitative image analysis, the HRME has the potential to 
be used to improve cervical cancer screening, especially in low-resource settings. 
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5. MULTIMODAL DIGITAL IMAGER FOR THE DETECTION OF CERVICAL 
NEOPLASIA IN LOW-RESOURCE SETTINGS 
 
5.1. Introduction 
Cervical cancer continues to be a major health problem among women in developing countries. 
More than 85% of cervical cancer deaths occur in developing countries [1], where screening 
tools that allow detection of precancerous and early stage cervical cancer are unavailable or 
inadequate [113, 114]. In 2008, there were estimated 234,000 deaths in developing countries due 
to cervical cancer compared to just over 41,000 deaths in developed countries [1]. In developed 
countries, organized screening tests such as the Papanicolaou smear (Pap smear) test have 
enabled precancerous lesions to be diagnosed and treated early, subsequently reducing new 
cervical cancer cases and mortality rates.  However, health care systems in many developing 
countries do not support Pap smear test or other types of screening tests. To be effective, these 
screening programs require relatively high-level infrastructure and well-trained personnel. 
In the last three decades, researchers have embarked on finding screening alternatives 
appropriate for low-resource settings. Today, the single most widely available screening method 
in developing countries for the single visit approach is VIA (visual inspection with acetic acid). 
This is a simple visual test, where the cervix is examined with the naked eye before and after 
DSSOLFDWLRQ RI  WR  DFHWLF DFLG 6XVSLFLRXV DUHDV XQGHUJR ³DFHWHRZKLWHQLQJ´ PHDQLQJ WKH
lesions turn white in comparison to healthy tissue. VIA is inexpensive, requires minimal 
infrastructure, and allows for immediate treatment, eliminating the need for a laboratory. VIA 
has shown promising results in differentiating normal or low-grade dysplasia from high-grade 
dysplasia or invasive carcinomas [7, 31, 41, 43, 97, 115]. Another approach based on visual 
LQVSHFWLRQ 9,/, 9LVXDO ,QVSHFWLRQ ZLWK /XJRO¶V ,RGLQH KDV DOVR EHHQ H[SORUHG  ,Q D
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multicenter study VILI presented improved sensitivity over VIA while maintaining similar 
specificity [43]. 
Other techniques investigated include HPV DNA testing.  HPV DNA testing has shown 
promising results when complementing cytology in primary screening [32, 33]. Some studies 
presented sensitivity and specificity of HPV DNA varying from 65% to 95% and 70% to 96% 
respectively [7]. These results suggest that HPV testing may be considered for primary cervical 
cancer screening in low-resource settings since it is easier to implement than cytology screening. 
Although it is anticipated that HPV DNA testing may reduce costs associated with unnecessary 
colposcopy, the currently available HPV tests are still relatively expensive to be fully 
implemented in low-resource settings; due to the need for laboratory infrastructure for 
processing. Also, currently available HPV tests require six hours to produce results, resulting in 
multiple clinic visits for screening and treatment. More recently, a rapid HPV test (careHPV) has 
been developed and promises to offer potential solutions to the limitations associated to the 
currently available HPV tests [35]. However, low specificity was reported, limiting the efficacy 
of see-and-treat programs.  
 
A number of optical techniques have recently been investigated as alternative detection 
methods in developing countries. Optical imaging has the capability to obtain and display wide-
field images of epithelial tissues in realǦtime [44]. Wide-field imaging systems enable a 
relatively large field of view (50-100 mm) to be visualized at moderate resolution under 
conventional whiteǦlight illumination, as well as in fluorescence and polarized light modes [62, 
63]. Supplementing conventional imaging with the use of polarized light, narrowband 
reflectance, and/or fluorescence imaging modes has been shown to improve sensitivity and 
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specificity for several types of cancer, by reducing specular glare, enhancing vascular contrast, 
and detecting alterations in tissue fluorescence associated with the presence of disease.  
Orfanoudaki et al. evaluated a wide-field, multispectral reflectance imaging system in a 
study involving 123 women. The system improved the diagnosis as the false positive-diagnostic 
rate was found to be 1.7%, compared to 22% and 24.4% of conventional colposcopy and Pap test 
respectively [68]. The United States Food and Drug Administration (FDA) in 2006 approved a 
trimodal imaging system called; LUMATM. LUMATM uses a 337nm UV nitrogen laser for 
fluorescence and two xenon flash lamps for reflectance. This system was evaluated in two 
prospective, randomized controlled studies, yielding higher sensitivities when compared to that 
of colposcopy [65, 70]. We previously developed a Multispectral Digital Colposcope MDC to 
measure multispectral autofluorescence and reflectance images of the cervix [62]. The MDC is a 
modified standard colposcope with the ability to measure reflectance and fluorescence images. 
Two excitation wavelengths, 330 and 440nm showed the greatest diagnostic power relative to 
histology [32]. In a different study, the MDC achieved a sensitivity of 79% and specificity of 
88% in distinguishing high-grade precancer from low-grade precancer or normal tissue [63]. 
These wide-field imaging devices have shown promising results for detecting abnormalities in 
the cervix; however, their use has been limited to medical facilities in developed countries due to 
their complexity, limited portability and high cost. 
 
In this study we present a portable, less complex, battery±powered, and robust wide-field 
system capable of operating in both fluorescence and reflectance. The multimodal digital imager 
(MDI) is based on similar principles to the devices that were previously developed in our lab [71, 
73], but was specifically designed to image the cervix. Table 3 shows the design criteria and the 
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actual performance of the MDI. The system includes three imaging modes: cross-polarization 
reflectance (to reduce specular reflection), narrowband green reflectance (to improve contrast of 
the vasculature), and fluorescence imaging using proflavine as a contrast agent.  
In low-resource areas where highly trained clinicians may not be available, automated algorithms 
to distinguish precancer from normal are very important to help healthcare providers with the 
diagnosis. Automated analysis techniques have the potential to reduce subjectivity and enhance 
reliability and reproducibility of the diagnosis. In this study computer-aided image analysis is 
also presented and its diagnostic performance reported. We investigated image parameters that 
have been previously found to correlate with diagnosis. These include average RGB pixel 
intensity values, the standard deviation of RGB pixel values, and ratios of the average RGB pixel 
values [62, 116 ± 119]. 
 
 
Table 3. Design criteria and performance of the MDI. 
 
 
 Design criteria Performance of the MDI 
Imaging modes - Cross polarized reflectance 
- Narrow band green reflectance 
- Fluorescence 
- Cross polarized reflectance 
- Narrow band green reflectance 
- Fluorescence  
Size Compact (fit inside a backpack) 6 x 4 x 6 inches  
Weight <10 lbs. 4 lbs. 
Power supply Battery powered Battery powered 
Resolution  50 ȝm to 100 ȝm 88.3 ȝm  
Field of view 35 - 60 mm 55 mm  
Working distance 250 ± 300 mm 250 mm 
Approximate cost <$5K $3,500 (laptop excluded) 
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5.2 Materials and Methods 
5.2.1 Instrumentation 
A schematic diagram of the multimodal digital imager (MDI) is shown in Fig. 18. The MDI 
incorporates a white LED (MWWHL3, Thorlabs) for illumination, narrowband excitation filter 
(Semrock-550/49nm, Semrock), fluorescence excitation filter (Semrock-445/25nm, Semrock), 
illumination polarizer (Chroma-21003a, Chroma), fluorescence emission filter (Semrock-
550/88nm, Chroma), observation polarizer (Chroma-21003a, Chroma), and CCD camera 
(GRAS-14S5C-C, Point Grey Research). Light from the LED is collimated by a 10 mm focal 
length lens, passes through the narrowband filter, polarizer or fluorescence filter depending on 
the imaging mode; another 50 mm focal length lens is then used to illuminate the entire cervix 
tissue.  The illuminated field of view (FOV) is 55 mm in diameter at a working distance (WD) of 
250 mm. Light emitted from the tissue is collected and directed through either a fluorescence 
emission filter or a polarizer depending on the imaging mode.  A 25 mm focal length macro lens 
(M118FM25 Megapixel, Tamron) is used to image the light onto a CCD camera. The polarizers, 
excitation and emission filters are mounted on a motorized filter wheel.  The entire system is 
controlled by a custom LabView graphical interface (Austin, Texas), and images are stored as 
JPEG files for later review and processing. 
 
The MDI specifications are listed in Table 3.  The resolution of the MDI was measured to be 
88.3 µm, which is within the acceptable range (50-100 µm) specified. This is particularly 
important because the system with a resolution exceeding 100 µm might fail to reveal changes in 
vascular atypia. The MDI weighs about 4 lb., measures 6 x 4 x 6 inches, and is powered by a 
rechargeable battery. The total cost of the MDI is approximately $3500, excluding the cost of the 
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laptop. Optical standards, including positive and negative reflectance standards, positive 
fluorescence slides, and a frosted quartz disk to serve as a negative fluorescent standard were 
used to quantify the performance of the MDI as well as to track any changes occurring in the 
device over time. For white light illumination, color balance was achieved by imaging a white 
balance sheet and adjusting the RGB ratio in software so that equal pixel intensity values were 
obtained in the red, green, and blue channels.  The fluorescence color slides were used as a 
standard to track any changes in color response or sensitivity of the camera over time in 
fluorescence mode. To confirm that there was no excitation leakage through the emission filter, 
the frosted quartz disk was imaged in fluorescence mode at exposure times and gain settings 
matching or exceeding those used for normal oral (lower lip) tissue fluorescence imaging. Signal 
from the negative control was less than 5% of that associated with tissue from a normal 
volunteer. 
In order to assess the degree to which application of proflavine increases the fluorescence 
intensity of normal mucosal tissue, the inner lip of two normal volunteers was imaged after 
application of 0.01% proflavine.  The proflavine fluorescence to autofluorescence ratio was 
found to be approximately 5.5. 
 
5.2.2 In vivo pilot study 
In order to determine the feasibility of using this optical system in low-resource areas, the MDI 
was tested in Botswana as a pilot clinical study. The Institutional Review Board at Rice 
University and the Health Research Division Office of the Botswana Ministry of Health 
approved the study protocol. Written informed consent documents were available in both English 
and the local national language (Setswana). All patients involved in the study were given written 
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informed consent. Patients at least 18 years of age with an abnormal Pap smear referred for 
colposcopy and who were not pregnant were eligible to participate in the study.  
Following application of 3% acetic acid the cervix was first examined by routine 
colposcopy. Abnormal cervical lesions were identified and noted by the study physician. The 
study physician described and classified each lesion as clinically high grade, clinically low 
grade, or clinically normal. Following colposcopic examination, the MDI was then advanced and 
several images were captured in cross-polarized white-light mode followed by narrow band 
green mode. Proflavine (0.01% w/v in sterile phosphate buffered saline) was then topically 
applied to the cervix, and MDI fluorescence images were recorded. Following fluorescence 
imaging, LuJRO¶V LRGLQHZDVDSSOLHG WR WKHFHUYL[DQGFROSRVFRSLF LPDJHVZHUH UHFRUGHG7KH
0',ZDVUHLQWURGXFHGDJDLQWRFROOHFWVHYHUDOSRVW/XJRO¶VLRGLQHLPDJHV 
 
Table 4. Distribution of sites imaged by MDI, grouped according to histopathology diagnosis 
 
Diagnostic Category Histopathology Diagnosis Number of Sites Imaged 
Normal/Benign 
Normal 7 
Inflammation 7 
Low Grade Dysplasia 
HPV Effect 10 
CIN 1 7 
High Grade Dysplasia 
CIN 2 2 
CIN3 12 
 
TOTAL 45 
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 Immediately after optical measurements, a clinically normal site was biopsied in addition 
to up to 2 abnormal/ suspicious sites and then submitted for histopathologic diagnosis. 
Diagnostic classification categories included normal, inflammation, HPV effect, grade 1 cervical 
intraepithelial neoplasia (CIN 1), grade 2 cervical intraepithelial neoplasia (CIN 2), and grade 3 
cervical intraepithelial neoplasia (CIN 3). CIN2 and CIN3 (high grade dysplasia) were 
categorized as neoplastic tissue and all others were categorized as non-neoplastic. 
 
  5.2.3 Data processing 
All digital images acquired with the MDI were stored as JPEG files on the computer and were 
later reviewed for quality control by a reviewer blinded to all diagnostic information. Images 
were discarded if they were out of focus or the biopsied site was not visible. All images which 
passed quality control and had a corresponding histopathologic diagnosis were analyzed with 
image analysis software (Matlab R2010b) to automatically extract quantitative parameters. 
Although narrow band green and fluorescence images were acquired, these images were not used 
LQWKLVVWXG\DVZHEHOLHYHGWKHDFHWRZKLWHQHGDQGSRVW/XJRO¶VLRGLQHLPDJHVWREHPRUHXVHIXO
for the current analysis. 
 
Quantitative analysis began with selection of a region-of-interest (ROI) that matched the size of a 
biopsy specimen from each image. From each ROI of the post-acetic acid images, features 
calculated included raw red, green, blue (RGB) pixel intensity values, and the relative 
contribution of R, B, G (i.e. R/(R+G+B), G/(R+G+B), B/(R+G+B)). These features have been 
previously quantified and reported to correlate with diagnosis [11, 18].  From each ROI of the 
post-/XJRO¶V LRGLQH LPDJH WKHIROORZLQJ LPDJHVIHDWXUHVZHUHFDOFXODWHG5*%SL[HO LQWHQVLW\
values, CYM (cyan, magenta, yellow and key) pixel intensity values from the CMYK color 
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model, and HSV (hue, saturation, and value)  pixel intensity values from the HSV color model. 
Finally, only two features from this list were selected as potentially useful for classification: 
relative red pixel intensity for the post-acetic acid images and hue pixel intensity values for the 
post-/XJRO¶VLRGLQHLPDJHV 
 
 
Figure 18. Schematic diagram of the Multimodal Digital Imager (MDI) 
Abbreviations:  
LED: Light-emitting diode 
CCD: Charge-coupled device (camera)  
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5.3 Results 
MDI images were acquired from 60 unique sites in 30 patients. Out of these, 8 sites were 
discarded due to lack of pathology diagnosis.  Seven more sites were left out because biopsy 
sites were not visible on the acquired images.  Table 4 summarizes the histopathologic diagnoses 
of the remaining 45 sites in 23 patients.  
Figure 19 shows images of the cervix from two patients obtained using the multimodal optical 
imager. The top row shows images from patient A. A black arrow (1) in the post- acetic acid 
image indicates an area of aceto-whitening lesion that was confirmed to be HPV effect (low 
grade and non-neoplastic) by histopathology. Arrow (2) indicates an area of normal cervical 
tissue which presents pinkish/reddish in color.  In comparison, the post-/XJRO¶V LRGLQH LPDJH
shows a yellowish area (corresponding to arrow 1) and a brownish area (corresponding to arrow 
2). The bottom row shows images from a patient with clinically apparent lesions (patient B). A 
thick aceto-white lesion is evident in the post-acetic image as indicated by the black arrow (1) 
and a thick mustard yellow of the corresponding area in the post-/XJRO¶V LRGLQH image. The 
histopathology report confirmed this area as neoplastic (CIN3). The black arrow (2) represents 
an area of normal cervical tissue. The lesion in patient B is thicker and slightly raised compared 
to the lesion in patient A. 
For each of the 45 measured and biopsied sites, relative red pixel intensity in the post acetic acid 
LPDJHVDQGPHDQSL[HOLQWHQVLW\RIKXHFKDQQHOLQSRVW/XJRO¶VLRGLQHLPDJHVZHUHFDOFXODWHG
Figure 20 shows scatter plots of this analysis for each of the 45 measurement sites, grouped 
according to histopathology. Figure 20a shows the mean intensity of relative red for each 
measured site.  A threshold value of 0.41 (shown as a dashed line in Fig. 20a) correctly classified 
non-neoplastic (normal/benign or low grade dysplasia) and neoplastic (high grade dysplasia) 
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sites with a sensitivity of 86% and specificity of 71%.  Figure 20b shows values of the mean 
pixel intensity of hue channel at the same sites as Fig. 20a. A threshold value of 0.05 correctly 
classified these measured sites into the same categories as described for mean intensity of 
relative red with a sensitivity of 86% and specificity of 51%.   
 
Figure 19: Images of the cervix from two patients obtained with the multimodal optical imager: 
(1st column) post acetic images, QGFROXPQSRVW/XJRO¶VLRGLQHLPDJHVUGFROXPQQDUURZ
band green images, and (4th column) fluorescence images. Arrows indicate region-of-interest; (1) 
abnormal/suspicious and (2) normal. 
 
 
Figure 21 shows the receiver operator characteristic (ROC) curve for a diagnostic algorithm, 
which combines the parameters derived in Figure 20. The Q-point indicated on the figure 
corresponds to a sensitivity of 86% and specificity of 74%. A combination of these features 
improved the specificity of each individual feature when used alone. For comparison, the 
sensitivity and specificity of clinical impression for the same sites were 57% and 84%, 
respectively.  
63 
 
 
 
Figure 20: 4XDQWLILFDWLRQ RI SRVW DFHWLF DFLG DQG SRVW /XJRO¶V LRGLQH LPDJHV EURNHQ GRZQ E\
histopathologic diagnosis.  (a) Mean relative red intensity at each of the 45 sites measured in the 
study.  (b) Mean pixel intensity of Hue channel for the same 45 sites shown in (a).  Dashed lines 
represent linear threshold values to discriminate between normal/benign/low grade dysplasia sites, 
and those with high grade dysplasia. For (a) a sensitivity of 86% and a specificity of 71% for 
separating samples diagnosed as high grade dysplasia from samples diagnosed as low grade 
dysplasia or normal/benign were measured whereas for (b) a sensitivity of 86% and a specificity 
of 51% were measured.  
 
5.4 Discussion  
This pilot study demonstrates the use of a low-cost, portable, multimodal optical imager that has 
the potential to improve cervical cancer screening in low-resource settings. The device is battery 
powered, incorporates LED illumination, and is capable of three imaging modes. Data from 23 
study subjects were analyzed to determine which imaging modalities provide the greatest optical 
contrast, and to determine if objective classification algorithms could be used to aid in 
identifying lesions in the cervix. In low-resource areas where knowledgeable manpower is 
limited, automated algorithms to distinguish precancer from normal tissue are important to help 
clinicians make an accurate diagnosis. Two features were selected as potentially useful for 
classification: 1) relative red pixel intensity for post acetic acid images and 2) hue pixel intensity 
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YDOXHVIRUSRVW/XJRO¶VLRGLQHLPDJHV5HODWLYHUHGSL[HOLQWHQVLW\UHVXOWHGLQEHWWHUFODVVLILFDWLRQ
performance with a sensitivity of 86% and specificity of 71%. Hue pixel intensity yielded the 
same sensitivity but a low specificity of 51%. The low specificity in the hue pixel intensity may 
be attributed to the presence of HPV infection, which tended to produce false positive images 
(yellowish staining). However, when these two features were used in combination, the specificity 
was better than that of each feature. This demonstrates the potential of incorporating multiple 
imaging modes.  
 
 
Figure 21: Classification of measured sites using both post acetic acid and post LXJRO¶V LRGLQH
Receiver operator characteristic curve for the features in Figure 3.  The star indicates the Q-point, 
with a sensitivity of 86% and a specificity of 74%.  For comparison, the sensitivity and specificity 
of clinical colposcopic impression for the same sites were 57% and 84%, respectively.   
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These results are encouraging; however, some limitations exist. First, the study involved 45 sites 
from 23 patients. A larger study is required to evaluate the diagnostic performance of the device. 
Second, the study showed the low specificity. This may be addressed by using this system in 
combination a high-resolution optical imaging system such as the high-resolution 
microendoscope (HRME) [111]. Wide-field optical imaging system can highlight suspicious 
areas with high sensitivity, while high-resolution optical imaging system can confirm the 
presence of disease with high specificity. Last, more research is need to determine the potential 
of analyses of narrow band green and fluorescence images which were acquired by the MDI but 
were excluded in this analysis.  
 In conclusion, we have built a low cost, portable, multimodal optical imaging system and 
coupled it with quantitative image algorithms. Although further work is needed to address the 
limitations in this study, the results from this pilot study suggest that this simple imaging device 
can potentially improve cervical cancer screening efforts in low-resource settings where 
screening programs for early detection are either inadequate or unavailable. 
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Chapter 6: WIDE-FIELD MULTIMODAL IMAGING AND HIGH-RESOLUTION 
MICROENDOSCOPE IMAGING FOR DETECTION OF CERVICAL NEOPLASIA 
 
6.1 Introduction 
Cervical cancer is the 2nd leading cause of cancer death among women in the developing world 
[1]. Women in developing countries are at greater risk of developing or dying from cervical 
cancer, due to unavailability or inadequate screening tools [1]. In contrast, women in the 
developed world are at much lower risk of developing or dying from cervical cancer as they have 
access to screening for precancer and early cancer by cervical cytology (the Pap test), and/or 
human papillomavirus (HPV) DNA testing. An abnormal screening test is followed by 
examination of the cervix using colposcopy with directed biopsies to diagnostically confirm the 
presence of disease, and treatment of neoplastic lesions. [95].  Unfortunately, it is challenging to 
implement these proven screening and diagnostic tools in developing countries, due to lack of 
financial resources, infrastructure, and trained personnel. 
Strategies such as visual inspection with acetiF 9,$ YLVXDO LQVSHFWLRQ ZLWK /XJRO¶V
iodine (VILI) have been developed and explored in low-resource countries. VIA and VILI are 
easy to implement in a single clinic visit and they are relatively inexpensive. The sensitivity of 
VIA and VILI to detect cervical dysplasia and cancer in low-resource settings has been shown to 
be similar to standard colposcopy, however, with a markedly lower specificity  
[38, 41, 107, 120]. Apart from low specificity, these tests are subjective; accuracy varies from 
one health-care provider to the other. 
HPV DNA testing has also been studied as a primary screening test for cervical cancer in 
developing countries [96, 122]. Although, promising results have been reported in these studies, 
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currently available HPV tests pose several additional challenges for low-resource settings.  They 
are expensive, require laboratory infrastructure for processing, and need a waiting time of one or 
more days for results.  A rapid-result HPV test (careHPV) which is currently in development is 
lower in cost and provides results within a few hours; however, low specificity has been reported 
[35]. Indeed, current see-and-treat programs are limited by the low specificity of HPV testing, 
VIA or VILI. There is an important need for affordable and effective tools to improve early 
detection of cervical precancer in low-resource settings. 
 
Optical imaging has emerged as a promising technique to improve detection of cervical 
neoplasia [76]. High performance optical imaging systems can be constructed at relatively low 
cost, and image analysis can be automated; thus, these technologies may provide a way to bridge 
the gap of cervical cancer screening for developing countries. Wide-field optical imaging 
systems can be used to acquire macroscopic images of the entire cervix, highlighting suspicious 
areas with high sensitivity [12, 63, 68]. High-resolution optical imaging systems can acquire 
microscopic images [45, 56, 79, 111], confirming the presence of disease with high specificity. 
The use of contrast agents with these systems can enhance image contrast, thus highlighting 
changes in biomarkers of cervical neoplasia [44]. 
 
We hypothesized that a combination of wide-field and high-resolution optical imaging of 
the cervix could assist in the detection of cervical neoplasia and that these techniques could be 
implemented effectively in low-resource settings. In this study, wide-field imaging and high-
resolution microendoscopy were performed with patients undergoing colposcopic evaluation for 
cervical cancer or pre-FDQFHU DW WKH ZRPHQ¶V FOLQLF DW 3ULQFHVV 0DULQD +RVSLWDO LQ %RWVZDQD
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Quantitative image analysis was used to develop a classification algorithm; sites determined to 
be positive by wide-field imaging were further classified by high-resolution microendosocopy.   
 
6.2 Materials and Methods 
6.2.1 Study population 
The study protocol was reviewed and approved by the Institutional Review Boards of the 
Health Research Division Office of the Botswana Ministry of Health and Rice University.   
Patients who were over 18 years of age, were not pregnant, and scheduled colposcopic 
assessment because of an abnormal Pap smear result were recruited to the study.  All 
participating subjects received and signed a written informed consent document which was 
available in both English and the local national language (Setswana). 
 
6.2.2 Imaging systems 
 A wide-field imaging system was originally designed for cross-polarized and 
fluorescence imaging; here, we used the system only for cross-polarized imaging.  The main 
components of the system for cross-polarized imaging include a white light LED (MC-E, Cree, 
Durham, NC), a macro lens (AF Micro-Nikon 105 mm, Nikon, Tokyo, Japan), and a digital 
camera (D7000, Nikon, Tokyo, Japan) as shown in Figure 22a.  Cross-polarized imaging was 
implemented using a polarizing beam splitter (48-545, Edmunds Optics, Barrington, NJ). The 
polarizing beam splitter directs linearly polarized white light to the sample; light reemitted from 
the sample orthogonal polarization is then transmitted via the polarizing beam splitter to a 
detector. The size of the illumination field is 50 mm in diameter at a working distance of 300 
mm. Light was collected through a Dichroic mirror and  a 435 nm longpass filter (Chroma, 
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HQ435LP) included in the system to enable fluorescence imaging.  An image of the sample is 
visualized on the LCD screen of the camera in real-time. The spatial resolution of the system was 
measured to be 79 µm. The entire system weighs 5.6 pounds and is powered by a rechargeable 
battery. 
A high-resolution microendoscope (HRME) system capable of obtaining images with 
subcellular resolution has been previously described [Muldoon, Pierce JOVE].  Briefly, the 
HRME consists of an LED at a wavelength peak of 455 nm for illumination (M455L2, Thorlabs, 
Newton, NJ), a fiber bundle (FIGH-30-850N, Fujikura, Tokyo, Japan) , a 10X NA objective lens 
(RMS10X, Thorlabs, Newton, NJ), and a CCD camera (GRAS-14S5M, Point Grey, Richmond, 
Canada).  Light from the LED is directed through the fiber bundle to the surface of the tissue.  
Fluorescence emission from the tissue travels through the same fiber bundle and is imaged onto a 
CCD camera as shown in Figure 22b.  The probe used in the current study provides a 720 Pm 
diameter field-of-view with 4.4 Pm spatial resolution.  
   
Histopathology 
diagnosis  
No. 
of site  
Clinical impression  
 
 Combined classification analysis 
No. of 
sites  
normal  
No. of 
sites 
abnormal  
%  
accuracy   
No. of 
sites 
negative  
No. of 
sites 
positive  
%  
accuracy  
          
Non-
neoplastic  
Normal  11  10  1  91  
 
10  1  91  
Inflammation  13  13  0  100  
 
11  2  85  
HPV effect  38  27  11  71  
 
31  17  82  
CIN 1  11  7  4  64  
 
10  1  91  
Neoplastic  
CIN 2  8  5  3  38  
 
4  4  50  
CIN 3  37  11  26  70  
 
4  33  89  
          
   Total  118        
  
      
 
 
Table 5. Histopathology diagnosis vs. clinical impression, and vs. imaging accuracy of the measured sites 
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6.2.3 Study procedure 
All subjects underwent routine colposcopic examination following application of 3% 
acetic acid.  The study physician identified, described and classified each lesion as clinically high 
grade, clinically low grade, or clinically normal.  Following colposcopic examination, several 
cross polarized white light images of the cervix were captured using the wide-field imaging 
system. Each image was acquired with a 12 ms integration time and ISO 6400. Next, proflavine 
(0.01% w/v in sterile phosphate buffered saline) was applied topically to the cervix using a 
cotton swab.  Following application of proflavine, HRME images were recorded with the probe 
slightly touching the tissue at each site defined by the physician.  Following HRME imaging, 
/XJRO¶VLRGLQHZDVDSSOLHd to the cervix and colposcopic images recorded as part of the standard 
of care at Princess Marina Hospital.  The wide-field system was then advanced to obtain cross 
polarized white light images.  After all optical measurements, each site imaged was biopsied, 
including one site which appeared normal by clinical impression.  Biopsy specimens were 
immediately sent for standard histologic analysis.  
Diagnostic classification by a single expert pathologist included normal, inflammation, 
HPV effect, grade 1 cervical intraepithelial neoplasia (CIN 1), grade 2 cervical intraepithelial 
neoplasia (CIN 2), grade 3 cervical intraepithelial neoplasia (CIN 3), carcinoma in situ (CIS), 
and squamous cell carcinoma (SCC) using standard histopathologic criteria [35, 122].  For the 
purpose of this data analysis, CIN 2, CIN3, CIS and SCC were categorized as neoplastic and all 
others were categorized as non-neoplastic. 
 
 
 
71 
 
 
6.2.4 Image Analysis ± WF Imaging 
First, post-acetic acid and post-/XJRO¶V LPDJHV REWDLQHG ZLWK WKH ZLGH-field imaging 
system underwent quality control assessment where by images were discarded if they appeared 
visually out of focus or a site biopsied was not visible.  Regions of interest (ROI) were then 
selected from images which met the quality control criteria; the ROI were sized corresponding to 
biopsy specimens, which was 4 mm2. Following ROI selection, the following image features 
were calculated from post acetic image to identify aceto-white epithelium: the raw red, green, 
blue (RGB) pixel intensity values, the cyan, yellow, magenta (CYM) pixel intensity values from 
the CMYK color model, and the relative contribution of R, B, G pixel to the total intensity [119].  
For each post-/XJRO¶VLPDJHWKHIROORZLQJLPDJHVIHDWXUHVZHUHFDOFXODWHG5*%SL[HOLQWHQVLty 
values, CYM pixel intensity values, and the hue, saturation, value (HSV) intensity values from 
the HSV color model.  
 
6.2.5 Image Analysis ± High-resolution Imaging (HRME) 
Data were reviewed to ensure that the HRME images met quality control metrics.  
Images were discarded if more than 50% of the field of view seemed out of focus, if there was 
evidence of motion artifact, contained significant debris, or if it seemed that thH¿EHU-optic probe 
was not in contact with the tissue.  Selection of regions of interest within images, data 
processing, data analysis, and histopathologic correlation for the HRME were identical to those 
reported previously [111]. The nuclear-to-cytoplasmic area ratio (N/C ratio) was quantified by 
image analysis software (MATLAB, Natick, MA).  The details of the software can be found here 
[111]. Briefly, the ROI was manually selected from each HRME image. Median filter was then 
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applied to the ROI to eliminate the fiber bundle patterns. Next, the image was converted to a 
binary image and a threshold applied to segment nuclei. Among the segmented nuclei, small 
objects assumed to be noise (<50 pixels) and large objects assumed to be clumps (>1500 pixels) 
were removed. Lastly, nuclear-to-cytoplasmic area (N/C) ratio was calculated by summing the 
number of pixels corresponding to nuclei and divided by the total number of pixels in the ROI. 
Nuclei appeared as bright dots on dark cytoplasm in each HRME image. The diagnostic 
classification algorithms and thresholds previously developed that study [111] were directly 
applied here to calculate the diagnostic performance of the HRME. 
 
6.2.6 Image Classification 
A two-step procedure was used to develop a classification algorithm to classify each 
measured site as neoplastic or non-neoplastic. In the first step, the image features extracted from 
both wide-field post-acetic acid images and post-/XJRO¶VLPDJHVZHUHXVHGWRFODVVLI\HDFK52,
of the measured site as potentially neoplastic or non-neoplastic. We developed an algorithm 
using wide-field parameters for this purpose. The classifier based on a two-class linear 
discriminant analysis was used to classify the data using image features; features were added one 
at a time until performance did not improve further.   The receiver operating characteristic 
(ROC) curve for the classifier was plotted for this step and the threshold was established on a 
point of the ROC curve by maximizing sensitivity so that any neoplastic sites would be less 
likely to be missed. In the second step, sites identified as potentially neoplastic by wide-field 
imaging were further evaluated with the high-resolution imaging parameter; the N/C ratio for 
HRME images was used to classify the sites as neoplastic or non-neoplastic using a previously 
developed algorithm [give reference].  Sites determined to be potentially non-neoplastic by wide-
73 
 
field imaging were considered to be non-neoplastic for the classification algorithm and were not 
evaluated further. The same data were used to both train and validate the approach.  
Histopathologic diagnosis was used as gold standard. 
 
 
6.3 Results 
 
6.3.1 Subject information  
A total of 90 patients were enrolled in this study.  Five patients were excluded because 
images were not obtained due system malfunction and four patients were also excluded because 
biopsies were not taken.  Images with corresponding pathology results were available from 167 
sites in 81 patients.  Out of these, thirteen sites were excluded because they were acquired 
columnar epithelium. The remaining images were reviewed using the QC criteria independently 
by three reviewers (TB, MKQ, and DS); 36 sites did not pass QC review. The resulting data set 
for further analysis consisted of images of 118 sites in 63 patients. Table 5 shows the histologic 
diagnosis for each measured site. According to histopathology (the gold standard), 73 sites were 
non-neoplastic (normal/ inflammation/ HPV effect/ CIN1) and 45 sites were neoplastic 
(CIN2/CIN3). In this study there were no cases of carcinoma in situ (CIS) or squamous cell 
carcinoma (SCC). 
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Figure 22. Schematic diagram of (a) the wide-field imaging system and (b) HRME 
 
6.3.2 Combined analysis  
Figure 23 shows wide-field and HRME images of sites that were correctly classified as 
non-neoplastic (a-c) and neoplastic (d-f) by both wide-field and high-resolution imaging. In the 
top row, a black circle indicates the ROI showing normal epithelium on a post-acetic acid image 
(a) and a white circle on a post-/XJRO¶V LPDJH E ZKLFK FRUUHVSRQGV WR WKH ORFDWLRQ RI WKH
HRME measurement. The corresponding HRME image (c) shows small, regularly spaced nuclei; 
the N/C ratio was calculated to be 0.09, which was consistent with the histopathologic diagnosis 
of normal.  In the bottom row, a black circle indicates the site showing an abnormal aceto-white 
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lesion (d) and a white circle indicates an abnormal mustard yellow lesion (e).  The corresponding 
HRME image (f) shows large, crowded, pleomorphic nuclei; the calculated N/C ratio is 0.27, 
which was consistent with the histopathologic diagnosis of CIN 3. 
 Figure 24 shows a site that was first incorrectly classified as neoplastic by both clinical 
impression and wide-field imaging, but correctly classified as non-neoplastic by HRME imaging.  
The site shows an aceto-white lesion and mustard yellow lesion on a post-acetic acid image and 
post-/XJRO¶VLPDJHUHVSHFWLYHO\EXWWKHFDOFXODWHG1&UDWio is 0.14, which consistent with non-
neoplastic diagnosis by histopathology of HPV effect.  
Figure 25a depicts a scatter plot of the hue intensity value of the post-/XJRO¶VLPDJHVIRU
each measured site, which was found to be the single best performing feature for wide-field 
imaging. The decision line which classifies sites as potential neoplastic or non-neoplastic is 
shown, achieving a sensitivity and specificity were 91% and 58%, respectively.  Figure 25b 
shows a scatter plot of the N/C ratio for sites determined to be positive by wide-field post-
/XJRO¶V LPDJLQJ 7KH WKUHVKROG YDOXH RI  SUHYLRXVO\ HVWDEOLVKHG KHUH >@ ZDV XVHG WR
classify the sites as neoplastic or non-neoplastic, resulting in a sensitivity of 82% and a 
specificity of 85%.  Table 5 summarizes accuracy of clinical impression and combined 
classification analysis versus histopathologic diagnosis. 
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Figure 23. Multi-modal optical imaging of the cervix. (a-c) a site classified as True Negative by both wide-
field imaging and HRME imaging.  Clinical impression: normal.  Histopathology: normal. (d-f) a site 
classified as True Positive by wide-field imaging and HRME imaging.  Clinical impression: abnormal.  
Histopathology: CIN3. (a,d) Cross-polarized post-acetic acid images; a black circle shows a region of 
interest corresponding to location of HRME measurement, (b, e) cross-polarized post-/XJRO¶V LPDJLQJD
white circle shows a corresponding region of interest. (C, f) HRME imaging. 
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Figure 24. Site classified as False Positive by wide-field imaging, but True Negative by HRME 
imaging.  Clinical impression: abnormal.  Histopathology: HPV effect.  (a) Cross-polarized post-
acetic acid image; a black circle shows a region of interest corresponding to location of HRME 
measurement. (b) Cross-polarized post-/XJRO¶V LPDJH D ZKLWH FLUFOH VKRZVD UHJLRQRI LQWHUHVW
corresponding to location of HRME measurement. (c) HRME image at the region of interest.  
 
 
 
 
Figure 25. (a) Scatter plot of hue intensity value for each site imaged with wide-field post-/XJRO¶V
imaging. The decision line which classifies sites as neoplastic or non-neoplastic is shown.  (b) 
Scatter plot of N/C ratio for sites determined to be positive by wide-ILHOGSRVW/XJRO¶V LPDJLQJ
and then imaged with the HRME. The decision line to classify sites as neoplastic or not using a 
threshold used for an independent HRME classification algorithm is shown. 
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6.4 Discussion 
 
Wide-field post-/XJRO¶V LPDJLQJ KDV D KLJK VHQVLWLYLW\ IRU GHWHFWLQJ FHUYLFDO OHVLRQV EXW PD\
have difficulty in distinguishing precancer from benign lesions such as HPV effect. The use of 
high-resolution microendoscope in combination with wide-field imaging provides the ability to 
minimize errors of misclassifying non-neoplastic lesions for neoplastic lesions as demonstrated 
by figure 24. This raises the possibility of a combined measurement procedure in which wide-
field imaging is used to identify suspicious lesions and guide the placement of the fiber bundle 
for HRME measurements.  
In this study, wide-field imaging alone was found to have a sensitivity of 91% and specificity of 
58%. The lower specificity may be attributed to the presence of HPV infection, which tended to 
incorrectly produce positive images (yellowish staining). The hue pixel intensity shown to 
misclassify HPV effect (non-neoplastic) as neoplastic. 
The HRME was found to have a sensitivity and specificity of 84% and 84%, respectively. This 
can be compared to the HRME of a previous study including 44 sites in 24 patients, in which a 
sensitivity and specificity of 86% and 87%, respectively, were obtained [111], demonstrating 
reliability of the N/C ratio from the HRME images to distinguish neoplastic from neoplastic of 
the cervix. 
 
The method of combining the wide-field imaging and high-resolution imaging results (the two-
step procedure) gave a sensitivity of 82% and a specificity of 85%. Although the performance of 
the HRME imaging alone showed the results comparable or better than those of the combined 
analysis, wide-field imaging play an important role by guiding HRME probe placement. It might 
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be difficult to acquire HRME images without prior macroscopic examination. Given this 
situation, this combined analysis may be appropriate. These results are encouraging and may 
potentially impact cervical cancer screening in low-resource settings. The high specificity of the 
multimodal optical imaging results suggests that this platform could potentially lower the 
number of over-treated lesions associated with current screening tests, subsequently enhancing 
WKH³VHH-and-WUHDW´SURJUDPVFXUUHQWO\LQXVHLQORZUHVRXUFHVHWWLQJV 
 
While findings are encouraging, our study has a number of limitations. More research is 
needed to determine the potential of analyses of fluorescence images which were acquired by the 
wide-field system but were excluded in this analysis. This might provide additional useful 
information and improve diagnostic accuracy of the multimodal optical imaging. More 
combination methods such as maximum posterior probability, minimum posterior probability 
and/or mean posterior probability may be explored to maximize accuracy. 
When combining data from wide-field imaging and high-resolution imaging, attention 
must be paid to registration of regions of interest within the wide-field image and sites measured 
with high-resolution system.  It may be helpful if the measurement procedure includes the 
collection of images of the probe placed on the measurement site.   
 
In summary, 118 sites in 63 patients were measured using both wide-field imaging and high-
resolution microendoscope in a low-resource setting.  Diagnostic algorithms and thresholds were 
established and applied to give quantitative analysis.  Wide-field imaging alone was found to 
have a sensitivity and specificity of 91% and 58%, respectively. The combined analysis 
produced a sensitivity of 82% and a specificity of 85%.  These results suggest that the overall 
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performance of noninvasive optical diagnostic methods may be enhanced through the use of 
platforms that combine both wide-field and high-resolution modalities. 
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Chapter 7:  CONCLUSION 
 In summary, a number of clinical studies were performed in a low resource setting to 
evaluate the performance of wide-field imaging and high-resolution imaging. The performance 
of each technique was optimized individually and in combination, for noninvasive in vivo 
diagnosis of cervical neoplasia. Quantitative image processing techniques and objective 
classification algorithms were also used to help aid in classifying measurement sites in human 
epithelium as neoplastic or non-neoplastic, a clinically important distinction. 
 
Initial study presented in Chapter 3 evaluated the ability of the high-resolution microendoscope 
+50( WR LGHQWLI\ FHUYLFDO QHRSODVLD LQ SDWLHQWV DW WKH ZRPHQ¶V FOLQLF DW 3ULQFHVV 0DULQD
Hospital in Botswana. Images were acquired from 52 sites in 26 patients. The images acquired 
by the microendoscope were assessed by both visual inspection by two expert observers and 
TXDQWLWDWLYH DQDO\VLV WR GLVFULPLQDWH QHRSODVWLF &,1  IURP QRQ-neoplastic cervical tissue. 
Results were compared to histopathology as the reference standard. Qualitative diagnoses by the 
expert HRME observers were compared with histopathologic diagnosis to calculate sensitivity 
and specificity. Observer #1 classified the images with a sensitivity and specificity of 86% and 
70% respectively. Observer #2 classified the images with a sensitivity and specificity of 93% and 
73% respectively. Quantitative analysis focused on assessment of nuclear size, since changes in 
nuclear size and nuclear-to-cytoplasmic (N/C) ratio are hallmark histopathologic features of 
cervical precancer. The sensitivity and specificity performance for this feature was 86% and 
87%, respectively. For comparison, the sensitivity and specificity of clinical colposcopic 
impression for the same sites were 64% and 83%, respectively. Chapter 4 presents HRME 
validation results. The goal of this study was to test the reliability and reproducibility of the 
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results previously acquired using the same system and the same algorithm in the same low-
resource setting. A total of 128 sites from 60 subjects were imaged; HRME images from each 
measured site were analyzed quantitatively using the same image analysis procedure to 
discriminate neoplastic (HGSIL or cancer) from non-neoplastic tissue (normal/benign or 
LGSIL). Results were compared to the gold standard of histopathology. High sensitivity of 90% 
and specificity 85% were reported in this study. These results are comparable to those previously 
reported. 
  Chapter 5 presents a portable, less complex, battery±powered, and robust wide-field 
system capable of operating in both fluorescence and reflectance. The performance of the 
multimodal optical imager (MDI) was measured, including using a USAF resolution target to 
verify that the MDI could resolve 88.3 micron lines. The feasibility of using this optical system 
in low-resource areas was also determined; the MDI was tested in Botswana as a pilot clinical 
study. In vivo MDI images were acquired from 60 unique sites in 30 patients. Computer-aided 
image analysis is also presented and its diagnostic performance reported. In low-resource areas 
where highly trained clinicians may not be available, automated algorithms to distinguish 
precancer from normal are very important to help healthcare providers with the diagnosis. 
Results were compared to the gold standard of histopathology. Relative red pixel intensity in the 
SRVWDFHWLFDFLG LPDJHVDQGPHDQSL[HO LQWHQVLW\RIKXHFKDQQHO LQSRVW/XJRO¶V LRGLQH LPDJHV
were found to be the two best performing features. The mean intensity of relative red for each 
measured site correctly classified non-neoplastic (normal/benign or low grade dysplasia) and 
neoplastic (high grade dysplasia) sites with a sensitivity of 86% and specificity of 71%, while the 
mean pixel intensity of hue channel correctly classified these measured sites into the same 
categories as described for mean intensity of relative red with a sensitivity of 86% and specificity 
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of 51%. A diagnostic algorithm that combines these two parameters was developed, and yielded 
a sensitivity of 86% and specificity of 74%. A combination of these features improved the 
specificity of each individual feature when used alone. For comparison, the sensitivity and 
specificity of clinical impression for the same sites were 57% and 84%, respectively.  
Chapter 6 presents combination wide-field imaging with high-resolution optical imaging 
of the cervix. A total 118 sites in 63 patients were analyzed using the features described in 
Chapters 3, 4 and 5. A two-class linear discriminant algorithm was developed using the features 
from the post-acetic acid and post-/XJRO¶V LPDJHV7KHKXHLQWHQsity value of the post-/XJRO¶V
images for each measured site was found to be the single best performing feature. Sites 
determined to be positive by wide-field imaging were then evaluated by high-resolution imaging.  
Sites determined to be negative by wide-field imaging were considered to be negative for the 
combined analysis and were not further evaluated. A sensitivity of 82% and specificity of 85% 
were reported. The results suggest that the combination of these techniques can assist in the 
detection of cervical neoplasia and that these techniques can be implemented effectively in a 
low-resource setting.  
 
There are several future research directions which could further assist clinicians in low 
resource settings to detect and treat cervical neoplasia.  
Firstly, more research is needed to characterize images acquired from endocervical tissue. All 
data was taken from the transformation zone, however a few were reported to contain normal 
columnar epithelium by pathology. HRME images of these sites demonstrated higher N/C ratio 
and this might be a potential limitation of our high-resolution imaging.  
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More work needs to be done to optimize all the imaging modalities of the wide-field systems. In 
this work only cross-polarized white light imaging was used. Narrowband reflectance, and/or 
fluorescence imaging modes might improve sensitivity and specificity, by reducing specular 
glare, enhancing vascular contrast, and detecting alterations in tissue fluorescence associated 
with the presence of disease. Continuing development of classification algorithms for both wide-
field and high-resolution systems could potentially provide a way to bridge the gap of cervical 
cancer screening for developing countries 
 
Building systems independent of a computer/Laptop can further reduce the cost and complexity 
of optical systems used in this dissertation. The cost of cellphones has dramatically gone down 
over the few years due to massive volume of wireless communication in the world. Hardware 
and software capabilities of cellphones have greatly advanced leading to utilization in medical 
imaging. A great opportunity exists in developing cellphone-based imaging systems. This can 
potentially make an impact in developing countries, where most of the cellphone usage has been 
reported. I propose the next be to convert the MDI and HRME into cellphone-based platforms. 
This will not only greatly reduced the cost associated with the devices but can improve 
telemedicine in these areas. That is, a less experienced health provider in a rural area may easily 
send images to a more experienced clinician in the city by just a click of a button for quick 
consultation, without the need of a computer and reliable Internet connection.  
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